KLA (KLAC) 10-Q 28 Apr 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Mar. 31, 2023	Apr. 17, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	000-09992
Entity Registrant Name	KLA CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	04-2564110
Entity Address, Address Line One	One Technology Drive,
Entity Address, City or Town	Milpitas,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95035
City Area Code	408
Local Phone Number	875-3000
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	KLAC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		137,198,902
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000319201
Current Fiscal Year End Date	--06-30

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Current assets:
Cash and cash equivalents	$ 1,568,513	$ 1,584,908
Marketable securities	1,321,696	1,123,100
Accounts receivable, net	1,940,067	1,811,877
Inventories	2,749,743	2,146,889
Other current assets	438,731	502,137
Total current assets	8,018,750	7,168,911
Land, property and equipment, net	984,271	849,929
Goodwill	2,278,817	2,320,049
Deferred income taxes	783,843	579,173
Purchased intangible assets, net	999,958	1,194,414
Other non-current assets	617,910	484,612
Total assets	13,683,549	12,597,088
Current liabilities:
Accounts payable	410,885	443,338
Deferred system revenue	533,791	500,969
Deferred service revenue	364,394	381,737
Other current liabilities	2,109,451	1,545,039
Total current liabilities	3,418,521	2,871,083
Long-term debt	5,889,740	6,660,718
Deferred tax liabilities	514,269	658,937
Deferred service revenue	176,260	124,618
Other non-current liabilities	1,001,978	882,642
Total liabilities	11,000,768	11,197,998
Commitments and contingencies
Stockholders’ equity:
Common stock and capital in excess of par value	1,996,773	1,061,940
Retained earnings	721,299	366,882
Accumulated other comprehensive loss	(35,291)	(27,471)
Total KLA stockholders’ equity	2,682,781	1,401,351
Non-controlling interest in consolidated subsidiaries	0	(2,261)
Total stockholders’ equity	2,682,781	1,399,090
Total liabilities and stockholders’ equity	$ 13,683,549	$ 12,597,088

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Revenues	$ 2,432,608	$ 2,288,676	$ 8,140,919	$ 6,725,144
Costs and expenses:
Costs of revenues	1,005,346	892,091	3,255,358	2,613,877
Research and development	328,276	285,189	979,617	808,373
Selling, general and administrative	238,393	216,489	735,469	623,229
Interest expense	74,774	39,978	223,449	116,142
Loss on extinguishment of debt	0	0	13,286	0
Other expense (income), net	(14,864)	8,644	(79,944)	23,985
Income before income taxes	800,683	846,285	3,013,684	2,539,538
Provision for income taxes	102,846	115,625	310,987	22,876
Net income	697,837	730,660	2,702,697	2,516,662
Less: Net income attributable to non-controlling interest	0	88	74	229
Net income attributable to KLA	$ 697,837	$ 730,572	$ 2,702,623	$ 2,516,433
Net income per share attributable to KLA
Basic (in dollars per share)	$ 5.06	$ 4.87	$ 19.26	$ 16.64
Diluted (in dollars per share)	$ 5.03	$ 4.83	$ 19.16	$ 16.52
Weighted-average number of shares:
Basic (in shares)	137,865	150,145	140,349	151,250
Diluted (in shares)	138,645	151,186	141,073	152,346
Product
Revenues:
Revenues	$ 1,903,484	$ 1,800,659	$ 6,562,501	$ 5,326,316
Service
Revenues:
Revenues	$ 529,124	$ 488,017	$ 1,578,418	$ 1,398,828

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 697,837	$ 730,660	$ 2,702,697	$ 2,516,662
Currency translation adjustments:
Cumulative currency translation adjustments	4,235	413	(8,015)	(3,733)
Income tax (provision) benefit	(15)	870	264	1,265
Net change related to currency translation adjustments	4,220	1,283	(7,751)	(2,468)
Cash flow hedges:
Net unrealized gains arising during the period	6,660	17,777	16,667	25,370
Reclassification adjustments for net gains included in net income	(2,824)	(992)	(25,960)	(3,122)
Income tax (provision) benefit	(352)	(4,023)	4,111	(5,047)
Net change related to cash flow hedges	3,484	12,762	(5,182)	17,201
Net change related to unrecognized losses and transition obligations in connection with defined benefit plans	86	467	561	1,675
Available-for-sale securities:
Net unrealized gains (losses) arising during the period	7,422	(12,270)	4,969	(15,860)
Reclassification adjustments for net losses included in net income	250	88	831	90
Income tax (provision) benefit	(1,651)	2,616	(1,248)	3,386
Net change related to available-for-sale securities	6,021	(9,566)	4,552	(12,384)
Other comprehensive income (loss)	13,811	4,946	(7,820)	4,024
Less: Comprehensive income attributable to non-controlling interest	0	88	74	229
Total comprehensive income attributable to KLA	$ 711,648	$ 735,518	$ 2,694,803	$ 2,520,457

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Total KLA Stockholders’ Equity	Common Stock and Capital in Excess of Par Value, Shares	Common Stock and Capital in Excess of Par Value, Amount	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Non- Controlling Interest
Beginning balance (in shares) at Jun. 30, 2021			152,776
Beginning balance at Jun. 30, 2021	$ 3,375,642	$ 3,377,554		$ 2,175,988	$ 1,277,123	$ (75,557)	$ (1,912)
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	1,068,417	1,068,417			1,068,417
Net income attributable to non-controlling interest	68						68
Other comprehensive income (loss)	(2,487)	(2,487)				(2,487)
Net issuance under employee stock plans (in shares)			160
Net issuance under employee stock plans	(46,532)	(46,532)		(46,532)
Repurchase of common stock (in shares)			(1,190)
Repurchase of common stock	(399,677)	(399,677)		(16,966)	(382,711)
Cash dividends and dividend equivalents declared	(161,561)	(161,561)			(161,561)
Stock-based compensation expense	25,216	25,216		25,216
Ending balance (in shares) at Sep. 30, 2021			151,746
Ending balance at Sep. 30, 2021	3,859,086	3,860,930		2,137,706	1,801,268	(78,044)	(1,844)
Beginning balance (in shares) at Jun. 30, 2021			152,776
Beginning balance at Jun. 30, 2021	3,375,642	3,377,554		2,175,988	1,277,123	(75,557)	(1,912)
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	2,516,433
Net income attributable to non-controlling interest	229
Other comprehensive income (loss)	4,024
Repurchase of common stock (in shares)			(3,833)
Repurchase of common stock	(1,394,217)
Ending balance (in shares) at Mar. 31, 2022			149,375
Ending balance at Mar. 31, 2022	4,078,624	4,080,307		2,179,229	1,972,611	(71,533)	(1,683)
Beginning balance (in shares) at Sep. 30, 2021			151,746
Beginning balance at Sep. 30, 2021	3,859,086	3,860,930		2,137,706	1,801,268	(78,044)	(1,844)
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	717,444	717,444			717,444
Net income attributable to non-controlling interest	73						73
Other comprehensive income (loss)	1,565	1,565				1,565
Net issuance under employee stock plans (in shares)			205
Net issuance under employee stock plans	31,157	31,157		31,157
Repurchase of common stock (in shares)			(1,104)
Repurchase of common stock	(429,874)	(429,874)		(15,604)	(414,270)
Cash dividends and dividend equivalents declared	(160,461)	(160,461)			(160,461)
Stock-based compensation expense	27,766	27,766		27,766			0
Ending balance (in shares) at Dec. 31, 2021			150,847
Ending balance at Dec. 31, 2021	4,046,756	4,048,527		2,181,025	1,943,981	(76,479)	(1,771)
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	730,572
Net income attributable to non-controlling interest	88						88
Other comprehensive income (loss)	4,946	4,946				4,946
Net issuance under employee stock plans (in shares)			67
Net issuance under employee stock plans	(16,661)	(16,661)		(16,661)
Repurchase of common stock (in shares)			(1,539)
Repurchase of common stock	(564,666)	(564,666)		(22,222)	(542,444)
Cash dividends and dividend equivalents declared	(159,498)	(159,498)			(159,498)
Stock-based compensation expense	37,087	37,087		37,087
Ending balance (in shares) at Mar. 31, 2022			149,375
Ending balance at Mar. 31, 2022	4,078,624	4,080,307		2,179,229	1,972,611	(71,533)	(1,683)
Beginning balance (in shares) at Jun. 30, 2022			141,804
Beginning balance at Jun. 30, 2022	1,399,090	1,401,351		1,061,940	366,882	(27,471)	(2,261)
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	1,025,991	1,025,991			1,025,991
Net income attributable to non-controlling interest	74						74
Other comprehensive income (loss)	(31,370)	(31,370)				(31,370)
Net issuance under employee stock plans (in shares)			171
Net issuance under employee stock plans	(54,950)	(54,950)		(54,950)
Repurchase of common stock (in shares)			(257)
Repurchase of common stock	(89,616)	(89,616)		(1,926)	(87,690)
Cash dividends and dividend equivalents declared	(186,216)	(186,216)			(186,216)
Stock-based compensation expense	34,982	34,982		34,982
Purchase of non-controlling interest	(4,294)	1,902		1,902			(6,196)
Disposal of non-controlling interest	8,383						8,383
Ending balance (in shares) at Sep. 30, 2022			141,718
Ending balance at Sep. 30, 2022	2,102,074	2,102,074		1,041,948	1,118,967	(58,841)	0
Beginning balance (in shares) at Jun. 30, 2022			141,804
Beginning balance at Jun. 30, 2022	1,399,090	1,401,351		1,061,940	366,882	(27,471)	(2,261)
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	2,702,623
Net income attributable to non-controlling interest	74
Other comprehensive income (loss)	(7,820)
Repurchase of common stock (in shares)			(4,913)
Repurchase of common stock	(943,310)
Ending balance (in shares) at Mar. 31, 2023			137,289
Ending balance at Mar. 31, 2023	2,682,781	2,682,781		1,996,773	721,299	(35,291)	0
Beginning balance (in shares) at Sep. 30, 2022			141,718
Beginning balance at Sep. 30, 2022	2,102,074	2,102,074		1,041,948	1,118,967	(58,841)	0
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	978,795	978,795			978,795
Other comprehensive income (loss)	9,739	9,739				9,739
Net issuance under employee stock plans (in shares)			170
Net issuance under employee stock plans	31,196	31,196		31,196
Repurchase of common stock (in shares)			(3,429)
Repurchase of common stock	(370,982)	(370,982)		870,811	(1,241,793)
Cash dividends and dividend equivalents declared	(185,967)	(185,967)			(185,967)
Stock-based compensation expense	38,405	38,405		38,405
Ending balance (in shares) at Dec. 31, 2022			138,459
Ending balance at Dec. 31, 2022	2,603,260	2,603,260		1,982,360	670,002	(49,102)	0
Increase (Decrease) in Stockholders' Equity
Net income attributable to KLA	697,837	697,837			697,837
Net income attributable to non-controlling interest	0
Other comprehensive income (loss)	13,811	13,811				13,811
Net issuance under employee stock plans (in shares)			57
Net issuance under employee stock plans	(16,154)	(16,154)		(16,154)
Repurchase of common stock (in shares)			(1,227)
Repurchase of common stock	(482,712)	(482,712)		(17,563)	(465,149)
Cash dividends and dividend equivalents declared	(181,391)	(181,391)			(181,391)
Stock-based compensation expense	48,130	48,130		48,130
Ending balance (in shares) at Mar. 31, 2023			137,289
Ending balance at Mar. 31, 2023	$ 2,682,781	$ 2,682,781		$ 1,996,773	$ 721,299	$ (35,291)	$ 0

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021
Statement of Stockholders' Equity [Abstract]
Cash dividends declared (in dollars per share)	$ 1.30	$ 1.30	$ 1.30	$ 1.05	$ 1.05	$ 1.05

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 2,702,697	$ 2,516,662
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	310,300	262,496
Loss on extinguishment of debt	13,286	0
Unrealized foreign exchange (gain) loss and other	(35,427)	14,669
Asset impairment charges	9,905	5,962
Disposal of non-controlling interest	8,270	0
Stock-based compensation expense	121,517	90,069
Gain on sale of business	(29,687)	0
Deferred income taxes	(321,712)	(382,975)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:
Accounts receivable	(153,630)	(318,271)
Inventories	(604,393)	(396,403)
Other assets	(30,427)	(23,729)
Accounts payable	(38,817)	82,376
Deferred system revenue	32,822	141,122
Deferred service revenue	35,551	81,216
Other liabilities	690,435	420,279
Net cash provided by operating activities	2,710,690	2,493,473
Cash flows from investing activities:
Net proceeds from sale of business	75,358	0
Business acquisitions, net of cash acquired	(27,144)	(470,887)
Capital expenditures	(262,908)	(234,160)
Purchases of available-for-sale securities	(960,837)	(733,386)
Proceeds from sale of available-for-sale securities	74,541	67,505
Proceeds from maturity of available-for-sale securities	699,363	524,677
Purchases of trading securities	(77,759)	(101,342)
Proceeds from sale of trading securities	70,279	95,734
Proceeds from other investments	1,020	795
Net cash used in investing activities	(408,087)	(851,064)
Cash flows from financing activities:
Payment of debt issuance costs	(6,515)	0
Proceeds from revolving credit facility	300,000	600,000
Repayment of debt	(1,087,250)	(345,000)
Common stock repurchases	(923,039)	(1,394,217)
Payment of dividends to stockholders	(553,046)	(480,926)
Issuance of common stock	33,908	36,912
Tax withholding payments related to vested and released restricted stock units	(73,704)	(68,948)
Contingent consideration payable and other, net	(5,027)	(1,100)
Purchase of non-controlling interest	(4,295)	0
Net cash used in financing activities	(2,318,968)	(1,653,279)
Effect of exchange rate changes on cash and cash equivalents	(30)	(8,568)
Net decrease in cash and cash equivalents	(16,395)	(19,438)
Cash and cash equivalents at beginning of period	1,584,908	1,434,610
Cash and cash equivalents at end of period	1,568,513	1,415,172
Supplemental cash flow disclosures:
Income taxes paid, net	451,243	355,176
Interest paid	198,906	116,791
Non-cash activities:
Contingent consideration payable - financing activities	(1,849)	15,086
Dividends payable - financing activities	5,856	5,375
Unsettled common stock repurchase - financing activities	15,943	6,000
Accrued purchases of land, property and equipment - investing activities	$ 14,390	$ 22,305

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION Basis of Presentation. For purposes of this report, “KLA,” the “Company,” “we,” “our,” “us” or similar references mean KLA Corporation and its majority-owned subsidiaries unless the context requires otherwise. The Condensed Consolidated Financial Statements have been prepared by us pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The unaudited interim Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for audited financial statements. The balance sheet as of June 30, 2022 was derived from the Company’s audited Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 but does not include all disclosures required by GAAP for audited financial statements. The unaudited interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal, recurring adjustments) necessary for a fair statement of the financial position, results of operations, comprehensive income, stockholders’ equity and cash flows for the periods indicated. These Condensed Consolidated Financial Statements and notes, however, should be read in conjunction with Item 8 “Financial Statements and Supplementary Data” included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. The Condensed Consolidated Financial Statements include the accounts of KLA and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The results of operations for the three and nine months ended March 31, 2023 are not necessarily indicative of the results that may be expected for any other interim period or for the full fiscal year ending June 30, 2023. Management Estimates. The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions in applying our accounting policies that affect the reported amounts of assets and liabilities (and related disclosure of contingent assets and liabilities) at the dates of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant Accounting Policies. There have been no material changes to our significant accounting policies summarized in Note 1 “Description of Business and Summary of Significant Accounting Policies” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Recent Accounting Pronouncements Recently Adopted There have been no recently adopted updates. Updates Not Yet Effective In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.

REVENUE

REVENUE	9 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Contract Balances The following table represents the opening and closing balances of accounts receivable, net, contract assets and contract liabilities as of the indicated dates. As of As of (Dollar amounts in thousands) March 31, 2023 June 30, 2022 $ Change % Change Accounts receivable, net $ 1,940,067 $ 1,811,877 $ 128,190 7 % Contract assets $ 125,019 $ 114,747 $ 10,272 9 % Contract liabilities $ 1,074,445 $ 1,007,324 $ 67,121 7 % Our payment terms and conditions vary by contract type, although the terms generally include a requirement of payment of 70% to 90% of total contract consideration within 30 to 60 days of product shipment, with the remainder payable within 30 days of acceptance. The change in contract assets during the nine months ended March 31, 2023 was mainly due to $96.9 million of revenue recognized for which the payment is subject to conditions other than passage of time, largely offset by $86.9 million of contract assets reclassified to net accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on our Condensed Consolidated Balance Sheets. The change in contract liabilities during the nine months ended March 31, 2023 was mainly due to an increase in the value of products and services billed to customers for which control of the products and services has not transferred to the customers, partially offset by recognition in revenue of $753.1 million that was included in contract liabilities as of June 30, 2022. The change in contract liabilities during the nine months ended March 31, 2022 was mainly due to an increase in the value of products and services billed to customers for which control of the products and services has not transferred to the customers, partially offset by the recognition in revenue of $495.8 million that was included in contract liabilities as of June 30, 2021. Contract liabilities are included in current and non-current liabilities on our Condensed Consolidated Balance Sheets. Remaining Performance Obligations As of March 31, 2023, we had $11.94 billion of remaining performance obligations, which represents our obligation to deliver products and services, and primarily consists of sales orders where written customer requests have been received. This amount includes customer deposits of $919.2 million and excludes contract liabilities of $1.07 billion as described above. We expect to recognize approximately 45% to 55% of these performance obligations as revenue beyond the next 12 months, but this estimate is subject to constant change depending upon supply chain constraints, customer slot change requests and potential elevated demand levels, which could require even longer lead times. In October 2022, the U.S. government issued new regulations that imposed new export licensing requirements for certain U.S. semiconductor and high-performance computing technology (including wafer fab equipment), for the use of such technology for certain end uses in the People’s Republic of China (“China”), and for the provision of support by U.S. Persons to certain advanced integrated circuit (“IC”) fabs located in China. The regulations impose export license requirements effectively on all KLA products and services to customers located in China that fabricate certain advanced logic, NAND and DRAM ICs. KLA is also restricted from providing certain U.S. origin tools, software and technology to certain wafer fab equipment manufacturers and maskshops located in China, absent an export license. We are taking appropriate measures to comply with these regulations and are applying for export licenses, when required, to avoid disruption to our customers’ operations. While some export licenses have been obtained by us or our customers, there can be no assurance that export licenses applied for by either us or our customers will be granted.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Our financial assets and liabilities are measured and recorded at fair value, except for our debt and certain equity investments in privately held companies. Equity investments without a readily available fair value are accounted for using the measurement alternative. The measurement alternative is calculated as cost minus impairment, if any, plus or minus changes resulting from observable price changes. See Note 8 “Debt” to our Condensed Consolidated Financial Statements for disclosure of the fair value of our Senior Notes, as defined in that Note. Our non-financial assets, such as goodwill, intangible assets, and land, property and equipment, are assessed for impairment when an event or circumstance indicates that an other-than-temporary decline in value may have occurred. Fair Value of Financial Instruments. We have evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts. The fair value of our cash equivalents, accounts receivable, accounts payable and other current assets and liabilities approximate their carrying amounts due to the relatively short maturity of these items. Fair Value Hierarchy. The authoritative guidance for fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below: Level 1 Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access. Level 2 Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 3 Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. There were no transfers between Level 1, Level 2 and Level 3 fair value measurements during the nine months ended March 31, 2023. The types of instruments valued based on quoted market prices in active markets include money market funds, certain U.S. Treasury securities, U.S. Government agency securities and equity securities. Such instruments are generally classified within Level 1 of the fair value hierarchy. The types of instruments valued based on other observable inputs include corporate debt securities, sovereign securities, municipal securities and certain U.S. Treasury securities. The market inputs used to value these instruments generally consist of market yields, reported trades and broker/dealer quotes. Such instruments are generally classified within Level 2 of the fair value hierarchy. The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-counter environment with a relatively high level of price transparency. The market participants generally are large financial institutions. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing intervals from public data sources and do not involve management judgment. These contracts are typically classified within Level 2 of the fair value hierarchy. The fair values of deferred payments and contingent consideration payable, the majority of which were recorded in connection with business combinations, were classified as Level 3 and estimated using significant inputs that were not observable in the market. See Note 6 “Business Combinations and Dispositions” to our Condensed Consolidated Financial Statements for additional information. Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs As of March 31, 2023 (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Cash equivalents: Corporate debt securities $ 1,063 $ — $ 1,063 $ — Money market funds and other 1,080,003 1,080,003 — — Marketable securities: Corporate debt securities 460,142 — 460,142 — Municipal securities 35,884 — 35,884 — Sovereign securities 5,016 — 5,016 — U.S. Government agency securities 117,370 117,370 — — U.S. Treasury securities 424,723 389,126 35,597 — Equity securities 19,839 19,839 — — Total cash equivalents and marketable securities (1) 2,144,040 1,606,338 537,702 — Other current assets: Derivative assets 20,291 — 20,291 — Other non-current assets: Executive Deferred Savings Plan 245,090 192,854 52,236 — Total financial assets (1) $ 2,409,421 $ 1,799,192 $ 610,229 $ — Liabilities Derivative liabilities $ (13,196) $ — $ (13,196) $ — Contingent consideration payable (19,299) — — (19,299) Total financial liabilities $ (32,495) $ — $ (13,196) $ (19,299) ________________ (1) Excludes cash of $315.5 million held in operating accounts and time deposits of $430.7 million (of which $172.0 million were cash equivalents) as of March 31, 2023. Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs As of June 30, 2022 (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Cash equivalents: Corporate debt securities $ 922 $ — $ 922 $ — Money market funds and other 948,027 948,027 — — U.S. Treasury securities 22,485 — 22,485 — Marketable securities: Corporate debt securities 472,047 — 472,047 — Municipal securities 60,724 — 60,724 — Sovereign securities 5,990 — 5,990 — U.S. Government agency securities 91,116 91,116 — — U.S. Treasury securities 348,026 344,559 3,467 — Equity securities 11,035 11,035 — — Total cash equivalents and marketable securities (1) 1,960,372 1,394,737 565,635 — Other current assets: Derivative assets 40,311 — 40,311 — Other non-current assets: Executive Deferred Savings Plan 224,188 176,928 47,260 — Total financial assets (1) $ 2,224,871 $ 1,571,665 $ 653,206 $ — Liabilities Derivative liabilities $ (34,315) $ — $ (34,315) $ — Deferred payments (2,350) — — (2,350) Contingent consideration payable (23,674) — — (23,674) Total financial liabilities $ (60,339) $ — $ (34,315) $ (26,024) ________________ (1) Excludes cash of $472.8 million held in operating accounts and time deposits of $274.9 million (of which $140.7 million were cash equivalents) as of June 30, 2022.

FINANCIAL STATEMENT COMPONENTS

FINANCIAL STATEMENT COMPONENTS	9 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
FINANCIAL STATEMENT COMPONENTS	FINANCIAL STATEMENT COMPONENTS Condensed Consolidated Balance Sheets As of As of (In thousands) March 31, 2023 June 30, 2022 Accounts receivable, net: Accounts receivable, gross $ 1,973,188 $ 1,832,508 Allowance for credit losses (33,121) (20,631) $ 1,940,067 $ 1,811,877 Inventories: Customer service parts $ 492,681 $ 402,121 Raw materials 1,503,024 1,042,916 Work-in-process 575,084 451,782 Finished goods 178,954 250,070 $ 2,749,743 $ 2,146,889 Other current assets: Contract assets $ 125,019 $ 114,747 Prepaid expenses 113,228 108,942 Deferred costs of revenues 112,074 124,487 Prepaid income and other taxes 37,834 89,713 Other current assets 50,576 64,248 $ 438,731 $ 502,137 Land, property and equipment, net: Land $ 72,286 $ 67,846 Buildings and leasehold improvements 810,173 712,751 Machinery and equipment 970,525 819,191 Office furniture and fixtures 57,554 44,957 Construction-in-process 147,932 110,079 2,058,470 1,754,824 Less: accumulated depreciation (1,074,199) (904,895) $ 984,271 $ 849,929 Other non-current assets: Executive Deferred Savings Plan (1) $ 245,090 $ 224,188 Operating lease right of use assets 201,014 126,444 Other non-current assets 171,806 133,980 $ 617,910 $ 484,612 Other current liabilities: Customer deposits $ 575,466 $ 394,016 Compensation and benefits 445,828 351,924 Income taxes payable 313,317 126,964 Executive Deferred Savings Plan (1) 245,734 225,867 Interest payable 56,049 39,683 Operating lease liabilities 33,522 32,218 Other liabilities and accrued expenses 439,535 374,367 $ 2,109,451 $ 1,545,039 Other non-current liabilities: Customer deposits $ 343,691 $ 204,914 Income taxes payable 317,263 367,052 Operating lease liabilities 137,811 81,369 Pension liabilities 75,716 78,525 Other non-current liabilities 127,497 150,782 $ 1,001,978 $ 882,642 ________________ (1) We have a non-qualified deferred compensation plan (known as “Executive Deferred Savings Plan” or “EDSP”) under which certain employees and non-employee directors may defer a portion of their compensation. The expense (benefit) associated with changes in the EDSP liability included in selling, general and administrative (“SG&A”) expense was $13.1 million and $(18.8) million in the three months ended March 31, 2023 and 2022, respectively, and was $14.7 million and $(7.8) million during the nine months ended March 31, 2023 and 2022, respectively. The amount of net gains (losses) associated with changes in the EDSP assets included in SG&A expense was $13.1 million and $(18.7) million in the three months ended March 31, 2023 and 2022, respectively, and was $14.7 million and $(8.0) million during the nine months ended March 31, 2023 and 2022, respectively. For additional details, refer to Note 1 “Description of Business and Summary of Significant Accounting Policies” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Accumulated Other Comprehensive Income (Loss) The components of Accumulated Other Comprehensive Income (Loss) (“AOCI”) as of the dates indicated below were as follows: (In thousands) Currency Translation Adjustments Unrealized Gains (Losses) on Available-for-Sale Securities Unrealized Gains (Losses) on Derivatives Unrealized Gains (Losses) on Defined Benefit Plans Total Balance as of March 31, 2023 $ (51,637) $ (10,934) $ 51,654 $ (24,374) $ (35,291) Balance as of June 30, 2022 $ (43,886) $ (15,486) $ 56,836 $ (24,935) $ (27,471) The effects on net income of amounts reclassified from AOCI to the Condensed Consolidated Statements of Operations for the indicated periods were as follows (in thousands; amounts in parentheses indicate debits or reductions to earnings): AOCI Components Three Months Ended Nine Months Ended Location in the Condensed Consolidated Statement of Operations March 31, March 31, 2023 2022 2023 2022 Unrealized gains (losses) on cash flow hedges from foreign exchange and interest rate contracts Revenues $ 1,421 $ 1,600 $ 31,954 $ 4,868 Costs of revenues and operating expenses 467 (329) (8,804) (909) Interest expense 936 (279) 2,810 (837) Net gains reclassified from AOCI $ 2,824 $ 992 $ 25,960 $ 3,122 Unrealized gains (losses) on available-for-sale securities Other expense (income), net $ (250) $ (88) $ (831) $ (90) The amount reclassified out of AOCI related to our defined benefit pension plans that was recognized as a component of net periodic cost for the three months ended March 31, 2023 and 2022 was $0.4 million in both periods, and for the nine months ended March 31, 2023 and 2022 was $1.2 million and $1.1 million, respectively. For additional details, refer to Note 13 “Employee Benefit Plans” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.

MARKETABLE SECURITIES

MARKETABLE SECURITIES	9 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
MARKETABLE SECURITIES	MARKETABLE SECURITIES The amortized cost and fair value of marketable securities as of the dates indicated below were as follows: As of March 31, 2023 (In thousands) Amortized Gross Gross Fair Corporate debt securities $ 466,754 $ 473 $ (6,022) $ 461,205 Money market funds and other 1,080,003 — — 1,080,003 Municipal securities 36,660 — (776) 35,884 Sovereign securities 5,021 — (5) 5,016 U.S. Government agency securities 118,073 127 (830) 117,370 U.S. Treasury securities 431,619 466 (7,362) 424,723 Equity securities (1) 3,211 16,628 — 19,839 Subtotal 2,141,341 17,694 (14,995) 2,144,040 Add: Time deposits (2) 430,719 — — 430,719 Less: Cash equivalents 1,253,063 — — 1,253,063 Marketable securities $ 1,318,997 $ 17,694 $ (14,995) $ 1,321,696 As of June 30, 2022 (In thousands) Amortized Gross Gross Fair Corporate debt securities $ 481,881 $ 3 $ (8,915) $ 472,969 Money market funds and other 948,027 — — 948,027 Municipal securities 61,973 — (1,249) 60,724 Sovereign securities 6,041 2 (53) 5,990 U.S. Government agency securities 92,273 26 (1,183) 91,116 U.S. Treasury securities 378,871 18 (8,378) 370,511 Equity securities (1) 3,211 7,824 — 11,035 Subtotal 1,972,277 7,873 (19,778) 1,960,372 Add: Time deposits (2) 274,873 — — 274,873 Less: Cash equivalents 1,112,146 — (1) 1,112,145 Marketable securities $ 1,135,004 $ 7,873 $ (19,777) $ 1,123,100 ________________ (1) Unrealized gains on equity securities included in our portfolio include the initial fair value adjustment recorded upon a security becoming marketable. (2) Time deposits excluded from fair value measurements. Our investment portfolio includes both corporate and government securities that have a maximum maturity of three years. The longer the duration of these securities, the more susceptible they are to changes in market interest rates and bond yields. As yields increase, those securities with a lower yield-at-cost show a mark-to-market unrealized loss. Most of our unrealized losses are due to changes in market interest rates and bond yields. We believe that we have the ability to realize the full value of all these investments upon maturity. As of March 31, 2023, we had 440 investments in a gross unrealized loss position. The following table summarizes the fair value and gross unrealized losses of our investments that were in an unrealized loss position as of the dates indicated below. As of March 31, 2023 Less than 12 Months 12 Months or Greater Total (In thousands) Fair Value Gross Fair Value Gross Fair Value Gross Corporate debt securities $ 163,334 $ (1,687) $ 221,831 $ (4,335) $ 385,165 $ (6,022) Municipal securities 8,711 (69) 27,173 (707) 35,884 (776) Sovereign securities 3,019 — 1,997 (5) 5,016 (5) U.S. Government agency securities 38,897 (125) 34,650 (705) 73,547 (830) U.S. Treasury securities 137,766 (1,945) 206,896 (5,417) 344,662 (7,362) Total $ 351,727 $ (3,826) $ 492,547 $ (11,169) $ 844,274 $ (14,995) As of June 30, 2022 (In thousands) Fair Value (1) Gross Unrealized Losses (1) Corporate debt securities $ 458,699 $ (8,915) Municipal securities 58,722 (1,249) Sovereign securities 2,963 (53) U.S. Government agency securities 60,285 (1,183) U.S. Treasury securities 336,819 (8,378) Total $ 917,488 $ (19,778) ________________ (1) As of June 30, 2022, our investments that were in a continuous loss position of 12 months or more, as well as the unrealized losses on those investments, were immaterial. The contractual maturities of securities classified as available-for-sale, regardless of their classification on our Condensed Consolidated Balance Sheets, as of the date indicated below were as follows: As of March 31, 2023 (In thousands) Amortized Cost Fair Value Due within one year $ 836,765 $ 845,394 Due after one year through three years 482,232 476,302 Total $ 1,318,997 $ 1,321,696 Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Realized gains and losses on available-for-sale securities for the three and nine months ended March 31, 2023 and 2022 were immaterial.

BUSINESS COMBINATIONS AND DISPO

BUSINESS COMBINATIONS AND DISPOSITIONS	9 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
BUSINESS COMBINATIONS AND DISPOSITIONS	BUSINESS COMBINATIONS AND DISPOSITIONS Business Combinations On August 9, 2022, we acquired a privately held company, primarily to secure the supply of materials for existing products, for aggregate purchase consideration of $32.7 million, payable in cash. We allocated the purchase consideration as follows: $30.0 million to identifiable intangible assets, $2.3 million to net tangible assets, $6.5 million to deferred tax liabilities and $6.8 million to goodwill. The purchase consideration allocation is preliminary, and as additional information becomes available, we may further revise it during the remainder of the measurement period, which will not exceed 12 months from the closing of the acquisition. The goodwill was assigned to the Wafer Inspection and Patterning reporting unit. On May 1, 2022, we acquired the outstanding shares of a privately held company for total purchase consideration of $8.6 million, paid in cash. We allocated the purchase consideration to the tangible and identifiable intangible assets acquired and liabilities assumed based on their fair values, and residual goodwill was allocated to the Wafer Inspection and Patterning reporting unit. On February 28, 2022, we completed the acquisition of 100% of the outstanding shares of ECI Technology, Inc. (“ECI”), a privately held company, for aggregate purchase consideration of $431.5 million, paid in cash, including a post-closing adjustment in the quarter ended September 30, 2022. KLA acquired ECI to extend and enhance our portfolio of products and services. We allocated the purchase consideration as follows: $208.4 million to identifiable intangible assets, $2.9 million to net tangible liabilities, $40.5 million to deferred tax liabilities and $266.4 million to goodwill. The goodwill was assigned to the Wafer Inspection and Patterning reporting unit. We have included the financial results of the acquisitions in our Condensed Consolidated Financial Statements from their respective acquisition dates, and these results were not material to our Condensed Consolidated Financial Statements. The goodwill recorded as a result of the above acquisitions was not deductible for tax purposes. As of March 31, 2023, we had $19.3 million of contingent consideration recorded for the acquisitions completed during fiscal years ended June 30, 2022 and 2019, all of which is classified as a current liability on the Condensed Consolidated Balance Sheet. Business Dispositions As of June 30, 2022, we owned approximately 94% of the outstanding equity interest in Orbograph Ltd. (“Orbograph”), a non-core business engaged in the development and marketing of character recognition solutions to banks, financial and other payment processing institutions and healthcare providers. On August 9, 2022, we acquired the non-controlling interest in Orbograph. On August 11, 2022, we sold our entire interest in Orbograph to a portfolio company of a private equity firm for total consideration of $110.0 million and net cash proceeds from the transaction of $75.4 million. We recognized a pre-tax gain from the sale of $29.7 million, which was recorded as part of other expense (income), net. Included in the sale were $26.5 million in tangible assets, $30.5 million in liabilities and $61.2 million in goodwill and intangible assets. For additional details of business combinations and assets held for sale, refer to Note 6 “Business Combinations and Dispositions” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.

GOODWILL AND PURCHASED INTANGIB

GOODWILL AND PURCHASED INTANGIBLE ASSETS	9 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND PURCHASED INTANGIBLE ASSETS	GOODWILL AND PURCHASED INTANGIBLE ASSETS Goodwill Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in business combinations. We have three reportable segments and five operating segments. The operating segments are determined to be the same as reporting units. For additional details, refer to Note 18 “Segment Reporting and Geographic Information” to our Condensed Consolidated Financial Statements. The following table presents changes in goodwill carrying value during the nine months ended March 31, 2023: (In thousands) Wafer Inspection and Patterning Global Service and Support ( “ GSS ” ) Specialty Semiconductor Process Printed Circuit Board (“PCB”) and Display Component Inspection Total Balance as of June 30, 2022 $ 725,737 $ 25,908 $ 681,858 $ 872,971 $ 13,575 $ 2,320,049 Acquired goodwill 6,776 — — — — 6,776 Goodwill disposal from sale of business (1) — — — (42,622) — (42,622) Goodwill adjustments (5,337) — — — — (5,337) Foreign currency adjustments (49) — — — — (49) Balance as of March 31, 2023 $ 727,127 $ 25,908 $ 681,858 $ 830,349 $ 13,575 $ 2,278,817 (1) Refer to the “Business Dispositions” section of Note 6 “Business Combinations and Dispositions” for more information on the sale of Orbograph. Goodwill is not subject to amortization but is tested for impairment annually during the third fiscal quarter, as well as whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In testing goodwill for impairment, we utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. When performing the qualitative assessment, we consider the following factors: stock price or market capitalization, changes in the industry and competitive environment, budget-to-actual revenue and profitability performance from the prior year and projected revenue and profitability trends for future years at our reporting units. If our qualitative assessment indicates that goodwill impairment is more likely than not, we perform a quantitative assessment by comparing the carrying value to the fair value of the reporting units. If the fair value is determined to be less than the carrying value, the amount of impairment is computed as the excess of the carrying value over the estimated fair value, not to exceed the carrying value of goodwill. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge. We performed the required annual goodwill impairment testing for all reporting units as of February 28, 2023, and concluded that goodwill was not impaired. As a result of our qualitative assessment, we determined that it was not necessary to perform the quantitative assessment. The next annual goodwill impairment assessment by reporting unit is scheduled to be performed in the third quarter of the fiscal year ending June 30, 2024. Purchased Intangible Assets The components of purchased intangible assets as of the dates indicated below were as follows: (In thousands) As of March 31, 2023 As of June 30, 2022 Category Range of Useful Lives (in years) Gross Accumulated Net Gross Accumulated Net Existing technology 4-8 $ 1,536,826 $ 796,369 $ 740,457 $ 1,523,691 $ 668,175 $ 855,516 Customer relationships 4-9 358,567 195,461 163,106 366,567 167,819 198,748 Trade name / Trademark 4-7 116,583 75,043 41,540 121,083 68,194 52,889 Order backlog and other <1-7 85,836 76,337 9,499 87,836 58,970 28,866 Intangible assets subject to amortization (1) 2,097,812 1,143,210 954,602 2,099,177 963,158 1,136,019 In-process research and development 61,322 15,966 45,356 64,457 6,062 58,395 Total $ 2,159,134 $ 1,159,176 $ 999,958 $ 2,163,634 $ 969,220 $ 1,194,414 (1) The disposition of Orbograph during the three months ended September 30, 2022 resulted in a decrease in the gross amount of intangible assets subject to amortization of $34.5 million, a decrease in accumulated amortization of $15.9 million, and a decrease in the net amount of intangible assets of $18.6 million. Refer to the “Business Dispositions” section of Note 6 “Business Combinations and Dispositions” for more information on the sale of Orbograph. Purchased intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be fully recoverable. Impairment indicators primarily include declines in our operating cash flows from the use of these assets. If impairment indicators are present, we are required to perform a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to these long-lived assets to their carrying value. As of March 31, 2023, there were no impairment indicators for purchased intangible assets. Amortization expense for purchased intangible assets for the periods indicated below was as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Amortization expense - Costs of revenues $ 45,446 $ 42,586 $ 135,958 $ 124,834 Amortization expense - SG&A 19,656 15,102 59,912 39,880 Amortization expense - Research and development 31 31 93 93 Total $ 65,133 $ 57,719 $ 195,963 $ 164,807 Based on the purchased intangible assets gross carrying amount recorded as of March 31, 2023, the remaining estimated annual amortization expense is expected to be as follows: Fiscal year ending June 30: Amortization (In thousands) 2023 (remaining three months) $ 64,655 2024 238,575 2025 222,123 2026 206,211 2027 129,630 2028 and thereafter 93,408 Total $ 954,602

DEBT

DEBT	9 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
DEBT	DEBT The following table summarizes our debt as of March 31, 2023 and June 30, 2022: As of March 31, 2023 As of June 30, 2022 Amount Effective Amount Effective Fixed-rate 4.650% Senior Notes due on November 1, 2024 $ 750,000 4.682 % $ 1,250,000 4.682 % Fixed-rate 5.650% Senior Notes due on November 1, 2034 250,000 5.670 % 250,000 5.670 % Fixed-rate 4.100% Senior Notes due on March 15, 2029 800,000 4.159 % 800,000 4.159 % Fixed-rate 5.000% Senior Notes due on March 15, 2049 400,000 5.047 % 400,000 5.047 % Fixed-rate 3.300% Senior Notes due on March 1, 2050 750,000 3.302 % 750,000 3.302 % Fixed-rate 4.650% Senior Notes due on July 15, 2032 1,000,000 4.657 % 1,000,000 4.657 % Fixed-rate 4.950% Senior Notes due on July 15, 2052 1,200,000 5.009 % 1,200,000 5.009 % Fixed-rate 5.250% Senior Notes due on July 15, 2062 800,000 5.259 % 800,000 5.259 % Revolving Credit Facility — — % 275,000 2.258 % Total 5,950,000 6,725,000 Unamortized discount/premium, net (18,139) (19,304) Unamortized debt issuance costs (42,121) (44,978) Total $ 5,889,740 $ 6,660,718 Reported as: Long-term debt $ 5,889,740 $ 6,660,718 Total $ 5,889,740 $ 6,660,718 Senior Notes and Debt Redemption In June 2022, we issued $3.00 billion aggregate principal amount of senior, unsecured notes (the “2022 Senior Notes”) as follows: $1.00 billion of 4.650% senior, unsecured notes due July 15, 2032; $1.20 billion of 4.950% senior, unsecured notes due July 15, 2052; and $800.0 million of 5.250% senior, unsecured notes due July 15, 2062. A portion of the net proceeds of the 2022 Senior Notes was used to complete a tender offer in July 2022 for $500.0 million of our Senior Notes due November 1, 2024 including associated redemption premiums, accrued interest and other fees and expenses. The transaction resulted in pre-tax net loss on extinguishment of debt of $13.3 million for the three months ended September 30, 2022. The remainder of the net proceeds were used for share repurchases and for general corporate purposes. Prior to June 2022, the following aggregate principal amounts of senior, unsecured long-term notes were issued in the following periods: $750.0 million in February 2020 (the “2020 Senior Notes”), $1.20 billion in March 2019 (the “2019 Senior Notes”) and $2.50 billion in November 2014 (the “2014 Senior Notes”). These, along with the 2022 Senior Notes, are collectively referred to as the “Senior Notes.” The original discounts on the Senior Notes are being amortized over the life of the debt. Interest is payable as follows: semi-annually on January 15 and July 15 of each year for the 2022 Senior Notes; semi-annually on March 1 and September 1 of each year for the 2020 Senior Notes; semi-annually on March 15 and September 15 of each year for the 2019 Senior Notes; and semi-annually on May 1 and November 1 of each year for the 2014 Senior Notes. The relevant indentures for the Senior Notes (collectively, the “Indenture”) include covenants that limit our ability to grant liens on our facilities and enter into sale and leaseback transactions. In certain circumstances involving a change of control followed by a downgrade of the rating of a series of Senior Notes by at least two of Moody’s Investors Service, S&P Global Ratings and Fitch Inc., unless we have exercised our rights to redeem the Senior Notes of such series, we will be required to make an offer to repurchase all or, at the holder’s option, any part, of each holder’s Senior Notes of that series pursuant to the offer described below (the “Change of Control Offer”). In the Change of Control Offer, we will be required to offer payment in cash equal to 101% of the aggregate principal amount of Senior Notes repurchased plus accrued and unpaid interest, if any, on the Senior Notes repurchased, up to, but not including, the date of repurchase. Based on the trading prices of the Senior Notes on the applicable dates, the fair value of the Senior Notes as of March 31, 2023 and June 30, 2022 was $5.79 billion and $6.39 billion, respectively. While the Senior Notes are recorded at cost, the fair value of the long-term debt was determined based on quoted prices in markets that are not active; accordingly, the long-term debt is categorized as Level 2 for purposes of the fair value measurement hierarchy. As of March 31, 2023, we were in compliance with all of our covenants under the Indenture associated with the Senior Notes. Revolving Credit Facility As of March 31, 2023, we have in place a renegotiated Credit Agreement dated June 8, 2022 (“Credit Agreement”) for an unsecured Revolving Credit Facility (“Revolving Credit Facility”) having a maturity date of June 8, 2027 that allows us to borrow up to $1.50 billion. Subject to the terms of the Credit Agreement, the Revolving Credit Facility may be increased by an amount up to $250.0 million in the aggregate. During the nine months ended March 31, 2023, we borrowed $300.0 million from the Revolving Credit Facility and repaid $575.0 million. As of March 31, 2023, we had no outstanding borrowings under the Revolving Credit Facility. We may borrow, repay and reborrow funds under the Revolving Credit Facility until the maturity date, at which time we may exercise two one-year extension options with the consent of the lenders. We may prepay outstanding borrowings under the Revolving Credit Facility at any time without a prepayment penalty. Borrowings under the Revolving Credit Facility can be made as Term Secured Overnight Financing Rate (“SOFR”) Loans or Alternate Base Rate (“ABR”) Loans, at the Company’s option. In the event that Term SOFR is unavailable, any Term SOFR elections will be converted to Daily Simple SOFR, if available. Each Term SOFR Loan will bear interest at a rate per annum equal to the applicable Adjusted Term SOFR rate, which is equal to the applicable Term SOFR rate plus 10 bps that shall not be less than zero, plus a spread ranging from 75 bps to 125 bps , as determined by the Company’s credit ratings at the time. Each ABR Loan will bear interest at a rate per annum equal to the ABR plus a spread ranging from 0 bps to 25 bps , as determined by the Company’s credit ratings at the time. We are also obligated to pay an annual commitment fee on the daily undrawn balance of the Revolving Credit Facility, which ranges from 4.5 bps to 12.5 bps , subject to an adjustment in conjunction with changes to our credit rating. The applicable interest rates and commitment fees are also subject to adjustment based on the Company’s performance against certain environmental sustainability key performance indicators related to greenhouse gas emissions and renewable electricity usage. As of March 31, 2023, we elected to pay interest on borrowings under the Revolving Credit Facility at the applicable Adjusted Term SOFR rate plus a spread of 100 bps and the applicable commitment fee on the daily undrawn balance of the Revolving Credit Facility was 9 bps. Under the Credit Agreement, the maximum leverage ratio on a quarterly basis is 3.50 to 1.00, covering the trailing four consecutive fiscal quarters for each fiscal quarter, which can be increased to 4.00 to 1.00 for a period of time in connection with a material acquisition or a series of material acquisitions. As of March 31, 2023, our maximum allowed leverage ratio was 3.50 to 1.00. We were in compliance with all covenants under the Credit Agreement as of March 31, 2023. For additional details, refer to Note 8 “Debt” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.

LEASES

LEASES	9 Months Ended
	Mar. 31, 2023
Leases [Abstract]
LEASES	LEASES We have operating leases for facilities, vehicles and other equipment. Our facility leases are primarily used for administrative functions, research and development (“R&D”), manufacturing, and storage and distribution. Our finance leases are not material. Our existing leases do not contain significant restrictive provisions or residual value guarantees; however, certain leases contain provisions for the payment of maintenance, real estate taxes or insurance costs by us. Our leases have remaining lease terms ranging from less than one year to 29 years, including periods covered by options to extend the lease when it is reasonably certain that the option will be exercised. Lease expense was $10.1 million and $29.2 million for the three and nine months ended March 31, 2023, respectively, and $9.2 million and $27.5 million for the three and nine months ended March 31, 2022, respectively. Expense related to short-term leases, which are not recorded on the Condensed Consolidated Balance Sheets, was not material for the three and nine months ended March 31, 2023 and 2022. As of March 31, 2023 and June 30, 2022, the weighted-average remaining lease term was 6.5 and 4.8 years, respectively, and the weighted-average discount rate for operating leases was 3.26% and 2.18%, respectively. Supplemental cash flow information related to leases was as follows: Nine Months Ended March 31, In thousands 2023 2022 Operating cash outflows from operating leases $ 29,630 $ 28,680 Right of use assets obtained in exchange for new operating lease liabilities $ 85,911 $ 20,698 Maturities of lease liabilities as of March 31, 2023 were as follows: Fiscal Year Ending June 30: (In thousands) 2023 (remaining three months) $ 10,503 2024 33,605 2025 32,942 2026 26,363 2027 21,511 2028 and thereafter 72,457 Total lease payments 197,381 Less imputed interest (26,048) Total $ 171,333

EQUITY, LONG-TERM INCENTIVE COM

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST	9 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST	EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST Equity Incentive Program As of March 31, 2023, 8.3 million shares remained available for issuance under our 2004 Equity Incentive Plan (the “2004 Plan”). For details of the 2004 Plan refer to Note 10 “Equity, Long-Term Incentive Compensation Plans and Non-Controlling Interest” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Assumed Equity Plans As part of the acquisition of Orbotech Ltd. (“Orbotech”) in February 2019, we assumed outstanding equity incentive awards under the following Orbotech equity incentive plans: (i) Equity Remuneration Plan for Key Employees of Orbotech and its Affiliates and Subsidiaries (as Amended and Restated in 2005), (ii) 2010 Equity-Based Incentive Plan, and (iii) 2015 Equity-Based Incentive Plan (collectively, the “Assumed Equity Plans”). As of March 31, 2023, there were no assumed awards outstanding, including options and restricted stock units (“RSUs”), under the Assumed Equity Plans. For details on the Assumed Equity Plans, refer to Note 10 “Equity, Long-Term Incentive Compensation Plans and Non-Controlling Interest” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Equity Incentive Plans - General Information The following table summarizes the combined activity under our equity incentive plans: (In thousands) Available For Grant (1) (2) Balance as of June 30, 2022 9,242 RSUs granted (3) (1,012) RSUs canceled 88 Balance as of March 31, 2023 8,318 __________________ (1) The number of RSUs reflects the application of the award multiplier of 2.0x to calculate the impact of the award on the shares reserved under the 2004 Plan. (2) No additional stock options, RSUs or other awards will be granted under the Assumed Equity Plans. (3) Includes RSUs granted to senior management during the nine months ended March 31, 2023 with performance-based vesting criteria (in addition to service-based vesting criteria for any of such RSUs that are deemed to have been earned) (“performance-based RSUs”). This line item includes all such performance-based RSUs granted during the nine months ended March 31, 2023 reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.6 million shares for the nine months ended March 31, 2023 reflects the application of the multiplier described above). The fair value of stock-based awards is measured at the grant date and is recognized as an expense over the employee’s requisite service period. For RSUs granted without “dividend equivalent” rights, fair value is calculated using the closing price of our common stock on the grant date, adjusted to exclude the present value of dividends which are not accrued on those RSUs. The fair value for RSUs granted with “dividend equivalent” rights is determined using the closing price of our common stock on the grant date. The following table shows stock-based compensation expense for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Stock-based compensation expense by: Costs of revenues $ 8,596 $ 6,543 $ 20,189 $ 14,475 R&D 13,289 8,482 30,437 18,077 SG&A 26,245 22,062 70,891 57,517 Total stock-based compensation expense $ 48,130 $ 37,087 $ 121,517 $ 90,069 Stock-based compensation capitalized as inventory as of March 31, 2023 and June 30, 2022 was $15.9 million and $8.6 million, respectively. Restricted Stock Units The following table shows the activity and weighted-average grant date fair values for RSUs during the nine months ended March 31, 2023: Shares (1) (In thousands) Weighted-Average Outstanding RSUs as of June 30, 2022 (2) 1,593 $ 218.03 Granted (3) 506 $ 390.53 Vested and released (264) $ 147.65 Withheld for taxes (190) $ 147.65 Forfeited (45) $ 179.82 Outstanding RSUs as of March 31, 2023 (2) 1,600 $ 293.58 __________________ (1) Share numbers reflect actual shares subject to awarded RSUs. (2) Includes performance-based RSUs. (3) This line item includes performance-based RSUs granted during the nine months ended March 31, 2023 reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.3 million shares for the nine months ended March 31, 2023). The RSUs granted by us generally vest as follows: (i) with respect to awards with only service-based vesting criteria, over periods ranging from two three The following table shows the weighted-average grant date fair value per unit for the RSUs granted, aggregate grant date fair value of RSUs vested, and tax benefits realized by us in connection with vested and released RSUs for the indicated periods : Three Months Ended March 31, Nine Months Ended March 31, (In thousands, except for weighted-average grant date fair value) 2023 2022 2023 2022 Weighted-average grant date fair value per unit $ 409.77 $ 388.03 $ 390.53 $ 358.38 Grant date fair value of vested RSUs $ 9,217 $ 10,150 $ 67,152 $ 57,453 Tax benefits realized by us in connection with vested and released RSUs $ 4,517 $ 3,993 $ 17,368 $ 17,914 As of March 31, 2023, the unrecognized stock-based compensation expense balance related to RSUs was $294.4 million, excluding the impact of estimated forfeitures, and will be recognized over a weighted-average remaining contractual term and an estimated weighted-average amortization period of 1.4 years. The intrinsic value of outstanding RSUs as of March 31, 2023 was $638.5 million. Cash-Based Long-Term Incentive Compensation We have adopted a cash-based long-term incentive (“Cash LTI”) program (“Cash LTI Plan”) for many of our employees as part of our employee compensation program. Executives and non-employee members of the Board of Directors do not participate in the Cash LTI Plan. During the nine months ended March 31, 2023 and 2022, we approved Cash LTI awards of $0.2 million and $15.7 million, respectively. Cash LTI awards issued to employees under the Cash LTI Plan will vest in three or four equal installments, with one-third or one-fourth of the aggregate amount of the Cash LTI award vesting on each anniversary of the grant date over a three Term Incentive Compensation Plans and Non-Controlling Interest” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Employee Stock Purchase Plan Our Employee Stock Purchase Plan (“ESPP”) provides that eligible employees may contribute up to 15% of their eligible earnings toward the semi-annual purchase of our common stock. The ESPP is qualified under Section 423 of the Internal Revenue Code. The employee’s purchase price is derived from a formula based on the closing price of the common stock on the first day of the offering period versus the closing price on the date of purchase (or, if not a trading day, on the immediately preceding trading day). The offering period (or length of the look-back period) under the ESPP has a duration of six months, and the purchase price with respect to each offering period, until otherwise amended, is equal to 85% of the lesser of (i) the fair market value of our common stock at the commencement of the applicable six months offering period or (ii) the fair market value of our common stock on the purchase date. We estimate the fair value of purchase rights under the ESPP using a Black-Scholes model. The fair value of each purchase right under the ESPP was estimated on the date of grant using the Black-Scholes model and the straight-line attribution approach with the following weighted-average assumptions: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Stock purchase plan: Expected stock price volatility 43.8 % 41.5 % 42.7 % 38.2 % Risk-free interest rate 3.9 % 0.1 % 2.5 % 0.1 % Dividend yield 1.4 % 1.0 % 1.6 % 1.2 % Expected life (in years) 0.5 0.5 0.5 0.5 The following table shows total cash received from employees for the issuance of shares under the ESPP, the number of shares purchased by employees through the ESPP, the tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP and the weighted-average fair value per share for the indicated periods: (In thousands, except for weighted-average fair value per share) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Total cash received from employees for the issuance of shares under the ESPP $ — $ — $ 33,793 $ 36,912 Number of shares purchased by employees through the ESPP — — 134 139 Tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP $ 616 $ 488 $ 1,540 $ 1,686 Weighted-average fair value per share based on Black-Scholes model $ 97.32 $ 107.45 $ 89.81 $ 94.91 The ESPP shares are replenished annually on the first day of each fiscal year by virtue of an evergreen provision. The provision allows for share replenishment equal to the lesser of 2.0 million shares or the number of shares which we estimate will be required to be issued under the ESPP during the forthcoming fiscal year. As of March 31, 2023, a total of 2.5 million shares were reserved and available for issuance under the ESPP. Quarterly Cash Dividends On March 1, 2023, we paid a quarterly cash dividend of $1.30 per share to stockholders of record as of the close of business on February 13, 2023. The total amount of regular quarterly cash dividends and dividend equivalents paid during the three months ended March 31, 2023 and 2022 was $180.9 million and $159.0 million, respectively. The total amount of regular quarterly cash dividends and dividend equivalents paid during the nine months ended March 31, 2023 and 2022 was $553.0 million and $480.9 million, respectively. The amount of accrued dividend equivalents payable for regular quarterly cash dividends on unvested RSUs with dividend equivalent rights as of March 31, 2023 and June 30, 2022 was $11.7 million and $11.2 million, respectively. These amounts will be paid upon vesting of the underlying RSUs.

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAM	9 Months Ended
	Mar. 31, 2023
Equity [Abstract]
STOCK REPURCHASE PROGRAM	STOCK REPURCHASE PROGRAM Our Board of Directors has authorized a program that permits us to repurchase our common stock, including increases in the authorized repurchase amount of $2.00 billion in the first quarter of fiscal 2022 and $6.00 billion in the fourth quarter of fiscal 2022. The stock repurchase program has no expiration date and may be suspended at any time. The intent of the program is, in part, to mitigate the potential dilutive impact related to our equity incentive plans and shares issued in connection with our ESPP as well as to return excess cash to our stockholders. Any and all share repurchase transactions are subject to market conditions and applicable legal requirements. On June 23, 2022, the Company executed accelerated share repurchase agreements (“ASR Agreements”) with two financial institutions to repurchase shares of our common stock in exchange for an upfront payment of $3.00 billion. The Company received initial deliveries totaling approximately 6.5 million shares of common stock in the fourth quarter of fiscal 2022, which represented 70% of the prepayment amount at the then-prevailing market price of the Company’s shares of common stock. The value of the shares to be delivered to the Company for the remainder of the upfront payment of $0.90 billion was recorded at that time as an unsettled forward contract, classified within stockholders’ equity. The total number of shares received under the ASR Agreements was based upon the volume weighted-average price of our common stock during the repurchase period, less an agreed-upon discount. Final settlement of the ASR Agreements occurred during the three months ended December 31, 2022, resulting in the delivery of 2.4 million additional shares, which yielded an average share price of $333.88 for the entire transaction. Under the authoritative guidance, share repurchases are recognized as a reduction to retained earnings to the extent available, with any excess recognized as a reduction of capital in excess of par value. In addition, as explained further in Note 13 “Income Taxes,” the Inflation Reduction Act of 2022 (“IRA”) introduced a 1% excise tax imposed on certain stock repurchases by publicly traded companies made after December 31, 2022. The excise tax is recorded as part of the cost basis of treasury stock repurchased after December 31, 2022 and, as such, is included in stockholders’ equity. As of March 31, 2023, an aggregate of $2.29 billion was available for repurchase under the stock repurchase program. Share repurchases for the indicated periods (based on the trade date of the applicable repurchase) were as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Number of shares of common stock repurchased 1,227 1,539 4,913 3,833 Total cost of repurchases $ 482,712 $ 564,666 $ 943,310 $ 1,394,217

NET INCOME PER SHARE

NET INCOME PER SHARE	9 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
NET INCOME PER SHARE	NET INCOME PER SHAREBasic net income per share is calculated by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is calculated by using the weighted-average number of common shares outstanding during the period, increased to include the number of additional shares of common stock that would have been outstanding if the shares of common stock underlying our outstanding dilutive RSUs had been issued. The dilutive effect of outstanding RSUs is reflected in diluted net income per share by application of the treasury stock method. The following table sets forth the computation of basic and diluted net income per share attributable to KLA: (In thousands, except per share amounts) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Numerator: Net income attributable to KLA $ 697,837 $ 730,572 $ 2,702,623 $ 2,516,433 Denominator: Weighted-average shares - basic, excluding unvested RSUs 137,865 150,145 140,349 151,250 Effect of dilutive RSUs and options 780 1,041 724 1,096 Weighted-average shares - diluted 138,645 151,186 141,073 152,346 Basic net income per share attributable to KLA $ 5.06 $ 4.87 $ 19.26 $ 16.64 Diluted net income per share attributable to KLA $ 5.03 $ 4.83 $ 19.16 $ 16.52 Anti-dilutive securities excluded from the computation of diluted net income per share 12 10 226 9

INCOME TAXES

INCOME TAXES	9 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The following table provides details of income taxes: Three Months Ended March 31, Nine Months Ended March 31, (Dollar amounts in thousands) 2023 2022 2023 2022 Income before income taxes $ 800,683 $ 846,285 $ 3,013,684 $ 2,539,538 Provision for income taxes $ 102,846 $ 115,625 $ 310,987 $ 22,876 Effective tax rate 12.8 % 13.7 % 10.3 % 0.9 % Our effective tax rate is lower than the U.S. federal statutory rate during the three months ended March 31, 2023 primarily due to the proportion of earnings generated in jurisdictions with tax rates lower than the U.S. statutory rate and the proportion of U.S. earnings eligible for the Foreign Derived Intangible Income deduction. Our effective tax rate is lower than the U.S. federal statutory rate during the nine months ended March 31, 2023 primarily due to a non-recurring tax benefit resulting from a decrease in our unrecognized tax benefits from the settlement of income tax examinations and a decrease in our deferred tax liabilities on unremitted earnings and unrealized gains. In the normal course of business, we are subject to examination by tax authorities throughout the world. We are subject to U.S. federal income tax examinations for all years beginning from the fiscal year ended June 30, 2018 and are under United States income tax examination for the fiscal years ended June 30, 2018, June 30, 2019 and June 30, 2020. We are subject to state income tax examinations for all years beginning from the fiscal year ended June 30, 2018. We are also subject to examinations in other major foreign jurisdictions, including Singapore and Israel, for all years beginning from the calendar year ended December 31, 2017. It is possible that certain examinations may be concluded in the next 12 months. The timing and resolution of income tax examinations are uncertain. Given the uncertainty around the timing of the resolution of these ongoing examinations, we are unable to estimate the full range of possible adjustments to our unrecognized tax benefits within the next 12 months. In August 2022, Orbotech executed a settlement agreement with the Israel Tax Authority (“ITA”) in resolution of tax examinations for fiscal years 2012 through 2014 and 2015 through 2018. The settlement agreement included a payment of approximately $25.7 million, including interest, to the ITA. Approximately $5.7 million of this payment may be refunded if and when the Israel Innovation Authority agrees to the amount of R&D expenses eligible for deduction during the above referenced years. In addition, Orbotech agreed to make an election in the current year to pay $16.2 million to the ITA related to previous “tax exempt” earnings under the historical Approved or Beneficial Enterprises regimes. The current year election to pay tax on the previous exempt earnings was made under the Temporary Order issued in the Israel Budget, which allows for a reduced tax rate on such earnings. Orbotech currently has no ongoing ITA examinations. Orbotech is subject to income tax examination in Israel for all years beginning from the calendar year ended December 31, 2019. Legislative Developments President Biden signed into law the CHIPS and Science Act of 2022 (“CHIPS Act,” where “CHIPS” stands for Creating Helpful Incentives to Produce Semiconductors) on August 9, 2022. The CHIPS Act provides for various incentives and tax credits among other items, including the Advanced Manufacturing Investment Credit (“AMIC”) which equals 25% of qualified investments in an advanced manufacturing facility that is placed in service after December 31, 2022. President Biden also signed into law the IRA on August 16, 2022. The IRA has several new provisions including a 15% corporate alternative minimum tax (“CAMT”) for certain large corporations that have at least an average of $1.0 billion of adjusted financial statement income over a consecutive three-tax-year period. The CAMT will be effective for us in the first quarter of our fiscal year ending June 30, 2024. The IRA also introduced a 1% excise tax imposed on certain stock repurchases by publicly traded companies made after December 31, 2022. We began recording the excise tax as part of the cost basis of treasury stock repurchased after December 31, 2022. Other than the excise tax imposed on certain stock repurchases as mentioned above, we are currently evaluating the applicability and impact of the other provisions in the IRA and the CHIPS Act on our Condensed Consolidated Financial Statements including our future cash flows.

LITIGATION AND OTHER LEGAL MATT

LITIGATION AND OTHER LEGAL MATTERS	9 Months Ended
	Mar. 31, 2023
Loss Contingency, Information about Litigation Matters [Abstract]
LITIGATION AND OTHER LEGAL MATTERS	LITIGATION AND OTHER LEGAL MATTERSWe are named from time to time as a party to lawsuits and other types of legal proceedings and claims in the normal course of our business. Actions filed against us include commercial, intellectual property (“IP”), customer, and labor and employment related claims, including complaints of alleged wrongful termination and potential class action lawsuits regarding alleged violations of federal and state wage and hour and other laws. In general, legal proceedings and claims, regardless of their merit, and associated internal investigations (especially those relating to IP or confidential information disputes) are often expensive to prosecute, defend or conduct, and may divert management’s attention and other Company resources. Moreover, the results of legal proceedings are difficult to predict, and the costs incurred in litigation can be substantial, regardless of outcome. We believe the amounts provided in our Condensed Consolidated Financial Statements are adequate in light of the probable and estimated liabilities. However, because such matters are subject to many uncertainties and the ultimate outcomes are not predictable, there can be no assurances that the actual amounts required to satisfy alleged liabilities from the matters described above will not exceed the amounts reflected in our Condensed Consolidated Financial Statements or will not have a material adverse effect on our results of operations, financial condition or cash flows.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Factoring. We have factoring agreements with financial institutions to sell certain of our trade receivables and promissory notes from customers without recourse. We do not believe we are at risk for any material losses as a result of these agreements. In addition, we periodically sell certain letters of credit (“LC”), without recourse, received from customers in payment for goods and services. The following table shows total receivables sold under factoring agreements and proceeds from sales of LC for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Receivables sold under factoring agreements $ 107,140 $ 63,094 $ 288,599 $ 210,130 Proceeds from sales of LC $ — $ 74,267 $ 69,247 $ 115,433 Factoring and LC fees for the sale of certain trade receivables were recorded in other expense (income), net and were not material for the periods presented. Purchase Commitments. We maintain commitments to purchase inventory from our suppliers as well as goods, services and other assets in the ordinary course of business. Our liability under these purchase commitments is generally restricted to a forecasted time-horizon as mutually agreed between the parties. This forecasted time-horizon can vary among different suppliers. Our estimate of our significant purchase commitments primarily for material, services, supplies and asset purchases is approximately $2.9 billion as of March 31, 2023, a majority of which are due within the next 12 months. Actual expenditures will vary based upon the volume of the transactions and length of contractual service provided. In addition, the amounts paid under these arrangements may be less in the event that the arrangements are renegotiated or canceled. Certain agreements provide for potential cancellation penalties. Cash LTI Plan. As of March 31, 2023, we have committed $183.7 million for future payment obligations under our Cash LTI Plan. The calculation of compensation expense related to the Cash LTI Plan includes estimated forfeiture rate assumptions. Cash LTI awards issued to employees under the Cash LTI Plan vest in three or four equal installments, with one-third or one-fourth of the aggregate amount of the Cash LTI award vesting on each anniversary of the grant date over a three Guarantees and Contingencies. We maintain guarantee arrangements available through various financial institutions for up to $77.5 million, of which $43.7 million had been issued as of March 31, 2023, primarily to fund guarantees to customs authorities for value-added tax and other operating requirements of our consolidated subsidiaries in Europe, Israel and Asia. Indemnification Obligations. Subject to certain limitations, we are obligated to indemnify our current and former directors, officers and employees with respect to certain litigation matters and investigations that arise in connection with their service to us. These obligations arise under the terms of our certificate of incorporation, our bylaws, applicable contracts, and Delaware and California law. The obligation to indemnify generally means that we are required to pay or reimburse the individuals’ reasonable legal expenses and possibly damages and other liabilities incurred by several of our current and former directors, officers and employees in connection with these matters. For example, we have paid or reimbursed legal expenses incurred in connection with the investigation of our historical stock option practices and the related litigation and government inquiries. Although the maximum potential amount of future payments we could be required to make under the indemnification obligations generally described in this paragraph is theoretically unlimited, we believe the fair value of this liability, to the extent estimable, is appropriately considered within the reserve we have established for currently pending legal proceedings. We are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party with respect to certain matters. Typically, these obligations arise in connection with contracts and license agreements or the sale of assets, under which we customarily agree to hold the other party harmless against losses arising therefrom, or provide customers with other remedies to protect against, bodily injury or damage to personal property caused by our products, non-compliance with our product performance specifications, infringement by our products of third-party IP rights and a breach of warranties, representations and covenants related to matters such as title to assets sold, validity of certain IP rights, non-infringement of third-party rights, and certain income tax-related matters. In each of these circumstances, payment by us is typically subject to the other party making a claim to and cooperating with us pursuant to the procedures specified in the particular contract. This usually allows us to challenge the other party’s claims or, in case of breach of IP representations or covenants, to control the defense or settlement of any third-party claims brought against the other party. Further, our obligations under these agreements may be limited in terms of amounts, activity (typically at our option to replace or correct the products or terminate the agreement with a refund to the other party), and duration. In some instances, we may have recourse against third parties and/or insurance covering certain payments made by us. In addition, we may, in limited circumstances, enter into agreements that contain customer-specific commitments on pricing, tool reliability, spare parts stocking levels, response time and other commitments. Furthermore, we may give these customers limited audit or inspection rights to enable them to confirm that we are complying with these commitments. If a customer elects to exercise its audit or inspection rights, we may be required to expend significant resources to support the audit or inspection, as well as to defend or settle any dispute with a customer that could potentially arise out of such audit or inspection. To date, we have made no significant accruals in our Condensed Consolidated Financial Statements for this contingency. While we have not in the past incurred significant expenses for resolving disputes regarding these types of commitments, we cannot make any assurance that we will not incur any such liabilities in the future. It is not possible to predict the maximum potential amount of future payments under these or similar agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these agreements have not had a material effect on our business, financial condition, results of operations or cash flows.

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	9 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIESThe authoritative guidance requires companies to recognize all derivative instruments, including foreign exchange contracts and rate lock agreements (collectively “derivatives”), as either assets or liabilities at fair value on the Condensed Consolidated Balance Sheets. In accordance with the accounting guidance, we designate foreign currency forward transactions and options contracts and interest rate forward transactions as cash flow hedges. In accordance with the accounting guidance, we also designate certain foreign currency exchange contracts as net investment hedge transactions intended to mitigate the variability of the value of certain investments in foreign subsidiaries. Our foreign subsidiaries operate and sell our products in various global markets. As a result, we are exposed to risks relating to changes in foreign currency exchange rates. We utilize foreign exchange contracts to hedge against future movements in foreign currency exchange rates that affect certain existing and forecasted foreign currency denominated sales and purchase transactions, such as the Japanese yen, the euro and the pound sterling. We routinely hedge our exposures to certain foreign currencies with various financial institutions in an effort to minimize the impact of certain currency exchange rate fluctuations. These foreign exchange contracts, designated as cash flow hedges, generally have maturities of less than 18 months. Cash flow hedges are evaluated for effectiveness monthly, based on changes in total fair value of the derivatives. If a financial counterparty to any of our hedging arrangements experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, we may experience material losses. Since fiscal 2015, we have entered into four sets of forward contracts to hedge the benchmark interest rate on portions of our Senior Notes prior to issuance (“Rate Lock Agreements”). Upon issuance of the associated debt, the Rate Lock Agreements were settled and their fair values were recorded within AOCI. The resulting gains and losses from these transactions are amortized to interest expense over the lives of the associated debt. We recognized net gains of $0.9 million and $2.8 million in the three and nine months ended March 31, 2023, respectively, for the amortization of the net of the Rate Lock Agreements that had been recognized in AOCI, which decreased the interest expense on a net basis. We recognized net expenses of $0.3 million and $0.8 million in the three and nine months ended March 31, 2022, respectively, for the amortization of the net of the Rate Lock Agreements that had been recognized in AOCI, which increased the interest expense on a net basis. As of March 31, 2023, the aggregate unamortized portion of the fair value of the forward contracts for the Rate Lock Agreements was a $52.0 million net gain. For derivatives that are designated and qualify as cash flow hedges, the effective portion of the gains or losses is reported in AOCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. For derivative contracts executed after adopting the new accounting guidance in fiscal 2019, the election to include time value for the assessment of effectiveness is made on all forward contracts designated as cash flow hedges. The change in fair value of the derivative is recorded in AOCI until the hedged item is recognized in earnings. The assessment of effectiveness of options contracts designated as cash flow hedges exclude time value. The initial value of the component excluded from the assessment of effectiveness is recognized in earnings over the life of the derivative contract. Any differences between changes in the fair value of the excluded components and the amounts recognized in earnings are recorded in AOCI. For derivatives that are designated and qualify as a net investment hedge in a foreign operation and that meet the effectiveness requirements, the net gains or losses attributable to changes in spot exchange rates are recorded in cumulative translation within AOCI. The remainder of the change in value of such instruments is recorded in earnings using the mark-to-market approach. Recognition in earnings of amounts previously recorded in cumulative translation is limited to circumstances such as complete or substantially complete liquidation or sale of the net investment in the hedged foreign operations. For derivatives that are not designated as hedges, gains and losses are recognized in other expense (income), net. We use foreign exchange contracts to hedge certain foreign currency denominated assets or liabilities. The gains and losses on these derivative instruments are largely offset by the changes in the fair value of the assets or liabilities being hedged. Derivatives in Hedging Relationships: Foreign Exchange Contracts and Rate Lock Agreements The gains (losses) on derivatives in cash flow and net investment hedging relationships recognized in other comprehensive income for the indicated periods were as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Derivatives Designated as Cash Flow Hedging Instruments: Rate lock agreements: Amounts included in the assessment of effectiveness $ — $ 10,069 $ — $ 10,069 Foreign exchange contracts: Amounts included in the assessment of effectiveness $ 6,008 $ 7,733 $ 16,720 $ 15,335 Amounts excluded from the assessment of effectiveness $ 652 $ (25) $ (53) $ (34) Derivatives Designated as Net Investment Hedging Instruments: Foreign exchange contracts (1) : $ 154 $ 1,850 $ 1,986 $ 1,386 __________________ (1) No amounts were reclassified from AOCI into earnings related to the sale of a subsidiary, as there were no such sales during the periods presented. The locations and amounts of designated and non-designated derivatives’ gains and losses reported in the Condensed Consolidated Statements of Operations for the indicated periods were as follows: Three Months Ended March 31, Three Months Ended March 31, 2023 2022 (In thousands) Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Total amounts presented in the Condensed Consolidated Statements of Operations in which the effects of cash flow hedges are recorded $ 2,432,608 $ 1,572,015 $ 74,774 $ (14,864) $ 2,288,676 $ 1,393,769 $ 39,978 $ 8,644 Gains (Losses) on Derivatives Designated as Hedging Instruments: Rate lock agreements: Amount of gains (losses) reclassified from AOCI to earnings $ — $ — $ 936 $ — $ — $ — $ (279) $ — Foreign exchange contracts: Amount of gains (losses) reclassified from AOCI to earnings $ 1,748 $ 467 $ — $ — $ 1,711 $ (329) $ — $ — Amount excluded from the assessment of effectiveness recognized in earnings $ (327) $ — $ — $ 765 $ (111) $ — $ — $ 568 Gains (Losses) on Derivatives Not Designated as Hedging Instruments: Amount of gains (losses) recognized in earnings $ — $ — $ — $ (9,066) $ — $ — $ — $ (2,802) Nine Months Ended March 31, Nine Months Ended March 31, 2023 2022 (In thousands) Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Total amounts presented in the Condensed Consolidated Statements of Operations in which the effects of cash flow hedges are recorded $ 8,140,919 $ 4,970,444 $ 223,449 $ (79,944) $ 6,725,144 $ 4,045,479 $ 116,142 $ 23,985 Gains (Losses) on Derivatives Designated as Hedging Instruments: Rate lock agreements: Amount of gains (losses) reclassified from AOCI to earnings $ — $ — $ 2,810 $ — $ — $ — $ (837) $ — Foreign exchange contracts: Amount of gains (losses) reclassified from AOCI to earnings $ 33,024 $ (8,804) $ — $ — $ 5,197 $ (909) $ — $ — Amount excluded from the assessment of effectiveness recognized in earnings $ (1,070) $ — $ — $ 1,675 $ (329) $ — $ — $ 1,883 Gains (Losses) on Derivatives Not Designated as Hedging Instruments: Amount of gains (losses) recognized in earnings $ — $ — $ — $ (2,773) $ — $ — $ — $ 4,261 The U.S. dollar equivalent of all outstanding notional amounts of foreign currency hedge contracts with maximum remaining maturities of approximately 14 months as of the dates indicated below, were as follows: As of As of (In thousands) March 31, 2023 June 30, 2022 Cash flow hedge contracts - foreign currency Purchase $ 192,875 $ 124,641 Sell $ 146,207 $ 176,259 Net investment hedge contracts - foreign currency Sell $ 87,157 $ 66,436 Other foreign currency hedge contracts Purchase $ 572,609 $ 565,586 Sell $ 296,379 $ 389,368 The locations and fair value of our derivatives reported in our Condensed Consolidated Balance Sheets as of the dates indicated below were as follows: Asset Derivatives Liability Derivatives Balance Sheet As of As of Balance Sheet As of As of Location March 31, 2023 June 30, 2022 Location March 31, 2023 June 30, 2022 (In thousands) Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts Other current assets $ 15,192 $ 20,595 Other current liabilities $ (1,504) $ 8,406 Total derivatives designated as hedging instruments 15,192 20,595 (1,504) 8,406 Derivatives not designated as hedging instruments Foreign exchange contracts Other current assets 5,099 19,716 Other current liabilities (11,692) 25,909 Total derivatives not designated as hedging instruments 5,099 19,716 (11,692) 25,909 Total derivatives $ 20,291 $ 40,311 $ (13,196) $ 34,315 The changes in AOCI, before taxes, related to derivatives for the indicated periods were as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Beginning AOCI $ 65,721 $ (20,831) $ 77,018 $ (25,830) Amount reclassified to earnings as net (gains) losses (2,824) (992) (25,960) (3,122) Net change in unrealized gains (losses) 6,814 19,627 18,653 26,756 Ending AOCI $ 69,711 $ (2,196) $ 69,711 $ (2,196) Offsetting of Derivative Assets and Liabilities We present derivatives at gross fair values in the Condensed Consolidated Balance Sheets. We have entered into arrangements with each of our counterparties, which reduce credit risk by permitting net settlement of transactions with the same counterparty under certain conditions. The information related to the offsetting arrangements for the periods indicated was as follows: As of March 31, 2023 Gross Amounts of Derivatives Not Offset in the Condensed Consolidated Balance Sheets (In thousands) Gross Amounts of Derivatives Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets Financial Instruments Cash Collateral Received Net Amount Derivatives - assets $ 20,291 $ — $ 20,291 $ (10,113) $ — $ 10,178 Derivatives - liabilities $ (13,196) $ — $ (13,196) $ 10,113 $ — $ (3,083) As of June 30, 2022 Gross Amounts of Derivatives Not Offset in the Condensed Consolidated Balance Sheets (In thousands) Gross Amounts of Derivatives Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets Financial Instruments Cash Collateral Received Net Amount Derivatives - assets $ 40,311 $ — $ 40,311 $ (12,291) $ — $ 28,020 Derivatives - liabilities $ (34,315) $ — $ (34,315) $ 12,291 $ — $ (22,024)

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS During the three and nine months ended March 31, 2023 and 2022, we purchased from, or sold to, several entities where one or more of our executive officers or members of our Board of Directors or their immediate family members were, during the periods presented, an executive officer or a board member of a subsidiary, including Citrix Systems, Inc., HP Inc., Keysight Technologies, Inc., Advanced Micro Devices, Inc., Microchip Technology Incorporated, Splunk Inc. and Ansys, Inc. The following table provides the transactions with these parties for the indicated periods (for the portion of such period that they were considered related): Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Total revenues $ 6,251 $ 4,485 $ 18,050 $ 5,108 Total purchases $ 462 $ 562 $ 3,742 $ 834

SEGMENT REPORTING AND GEOGRAPHI

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION	9 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
SEGMENT REPORTING AND GEOGRAPHIC INFORMATION	SEGMENT REPORTING AND GEOGRAPHIC INFORMATION Accounting Standards Codification 280, Segment Reporting, establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. We have three reportable segments: Semiconductor Process Control; Specialty Semiconductor Process; and PCB, Display and Component Inspection. The reportable segments are determined based on several factors including, but not limited to, customer base, homogeneity of products, technology, delivery channels and similar economic characteristics. Prior to July 1, 2022, we had a fourth segment, Other, but core assets were sold and there are no longer operations. Semiconductor Process Control The Semiconductor Process Control segment offers a comprehensive portfolio of inspection, metrology and data analytics products, and related services, which helps IC manufacturers achieve target yield throughout the entire semiconductor fabrication process, from R&D to final volume production. Our differentiated products and services are designed to provide comprehensive solutions that help our customers accelerate development and production ramp cycles, achieve higher and more stable semiconductor die yields and improve their overall profitability. This reportable segment is composed of two operating segments, Wafer Inspection and Patterning and GSS. Specialty Semiconductor Process The Specialty Semiconductor Manufacturing segment develops and sells advanced vacuum deposition and etching process tools, which are used by a broad range of specialty semiconductor customers, including manufacturers of microelectromechanical systems (“MEMS”), radio frequency (“RF”) communication chips and power semiconductors for automotive and industrial applications. This reportable segment is composed of one operating segment. PCB, Display and Component Inspection The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality, pattern the desired electronic circuitry on the relevant substrate and perform three-dimensional shaping of metalized circuits on multiple surfaces. This reportable segment is composed of two operating segments, PCB and Display and Component Inspection. The CODM assesses the performance of each operating segment and allocates resources to those segments based on total revenues and segment gross profit and does not evaluate the segments using discrete asset information. Segment gross profit excludes corporate allocations and effects of changes in foreign currency exchange rates, amortization of intangible assets, amortization of inventory fair value adjustments, and transaction costs associated with our acquisitions related to costs of revenues. The following is a summary of results for each of our three reportable segments for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Semiconductor Process Control: Revenues $ 2,171,557 $ 1,979,295 $ 7,226,711 $ 5,810,580 Segment gross profit 1,367,886 1,284,450 4,622,905 3,789,316 Specialty Semiconductor Process: Revenues 128,438 117,253 414,390 332,020 Segment gross profit 65,328 61,521 216,408 176,516 PCB, Display and Component Inspection: Revenues 131,923 192,533 502,627 583,318 Segment gross profit 43,361 93,298 182,899 270,096 Totals: Revenues for reportable segments $ 2,431,918 $ 2,289,081 $ 8,143,728 $ 6,725,918 Segment gross profit $ 1,476,575 $ 1,439,269 $ 5,022,212 $ 4,235,928 The following table reconciles total revenues for reportable segments to total revenues for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Total revenues for reportable segments $ 2,431,918 $ 2,289,081 $ 8,143,728 $ 6,725,918 Corporate allocations and effects of changes in foreign currency exchange rates 690 (405) (2,809) (774) Total revenues $ 2,432,608 $ 2,288,676 $ 8,140,919 $ 6,725,144 The following table reconciles total segment gross profit to income before income taxes for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Total segment gross profit $ 1,476,575 $ 1,439,269 $ 5,022,212 $ 4,235,928 Acquisition-related charges, corporate allocations, and effects of changes in foreign currency exchange rates (1) 49,313 42,684 136,651 124,661 R&D 328,276 285,189 979,617 808,373 SG&A 238,393 216,489 735,469 623,229 Interest expense 74,774 39,978 223,449 116,142 Loss on extinguishment of debt — — 13,286 — Other expense (income), net (14,864) 8,644 (79,944) 23,985 Income before income taxes $ 800,683 $ 846,285 $ 3,013,684 $ 2,539,538 __________________ (1) Acquisition-related charges primarily include amortization of intangible assets, amortization of inventory fair value adjustments and other acquisition-related costs classified or presented as part of costs of revenues. Our significant operations outside the United States include manufacturing facilities in China, Germany, Israel and Singapore and sales, marketing and service offices in Japan, the rest of the Asia Pacific region and Europe. For geographical revenue reporting, revenues are attributed to the geographic location in which the customer is located. Long-lived assets consist of land, property and equipment, net, and are attributed to the geographic region in which they are located. The following is a summary of revenues by geographic region, based on ship-to location, for the indicated periods: (Dollar amounts in thousands) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Revenues: China $ 635,018 26 % $ 709,502 31 % $ 2,156,380 26 % $ 1,939,195 29 % Taiwan 478,855 20 % 515,097 22 % 1,996,188 24 % 1,918,623 29 % Korea 468,226 19 % 474,019 21 % 1,466,624 18 % 1,036,297 16 % North America 341,376 14 % 219,267 10 % 941,771 12 % 668,601 10 % Japan 215,531 9 % 132,829 6 % 702,986 9 % 504,278 7 % Europe and Israel 209,136 9 % 164,246 7 % 542,823 7 % 426,881 6 % Rest of Asia 84,466 3 % 73,716 3 % 334,147 4 % 231,269 3 % Total $ 2,432,608 100 % $ 2,288,676 100 % $ 8,140,919 100 % $ 6,725,144 100 % The following is a summary of revenues by major product categories for the indicated periods: (Dollar amounts in thousands) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Revenues: Wafer Inspection $ 1,027,191 42 % $ 919,072 40 % $ 3,386,273 42 % $ 2,910,616 43 % Patterning 611,631 25 % 610,821 27 % 2,206,263 27 % 1,559,197 23 % Specialty Semiconductor Process 114,896 5 % 105,832 5 % 374,882 5 % 303,884 5 % PCB, Display and Component Inspection 69,495 3 % 123,384 5 % 312,582 4 % 383,021 6 % Services 529,124 22 % 488,017 21 % 1,578,418 19 % 1,398,828 21 % Other 80,271 3 % 41,550 2 % 282,501 3 % 169,598 2 % Total $ 2,432,608 100 % $ 2,288,676 100 % $ 8,140,919 100 % $ 6,725,144 100 % Wafer Inspection and Patterning products are offered in the Semiconductor Process Control segment. Services are offered in multiple segments. Other includes primarily refurbished systems, remanufactured legacy systems, and enhancements and upgrades for previous-generation products that are part of the Semiconductor Process Control segment. In the three months ended March 31, 2023, two customers accounted for approximately 18% and 16% of total revenues, respectively. In the three months ended March 31, 2022, two customers accounted for approximately 17% and 16% of total revenues, respectively. In the nine months ended March 31, 2023, two customers accounted for approximately 20% and 15% of total revenues, respectively. In the nine months ended March 31, 2022, two customers accounted for approximately 22% and 12% of total revenues. Two customers and one customer on an individual basis accounted for greater than 10% of net accounts receivable at March 31, 2023 and at June 30, 2022, respectively. Land, property and equipment, net by geographic region as of the dates indicated below were as follows: As of As of (In thousands) March 31, 2023 June 30, 2022 Land, property and equipment, net: United States $ 644,799 $ 547,454 Singapore 152,275 146,057 Israel 88,277 72,791 Europe 60,827 55,370 Rest of Asia 38,093 28,257 Total $ 984,271 $ 849,929

RESTRUCTURING CHARGES

RESTRUCTURING CHARGES	9 Months Ended
	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
RESTRUCTURING CHARGES	RESTRUCTURING CHARGES From time to time, management approves restructuring plans including workforce reductions, one of which was announced and substantially completed in the three months ended March 31, 2023, in an effort to streamline operations. Restructuring charges were $19.1 million and zero for the three months ended March 31, 2023 and 2022, respectively. Restructuring charges were $35.9 million and $0.9 million for the nine months ended March 31, 2023 and 2022, respectively. The fiscal year 2023 charges include one-time transaction bonuses triggered by the sale of Orbograph as well as severance and associated acceleration of certain stock-based compensation expenses resulting from a workforce reduction. As of March 31, 2023 and June 30, 2022, the accrual for restructuring charges was $20.2 million and $2.1 million, respectively.

BASIS OF PRESENTATION (Policies

BASIS OF PRESENTATION (Policies)	9 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation. For purposes of this report, “KLA,” the “Company,” “we,” “our,” “us” or similar references mean KLA Corporation and its majority-owned subsidiaries unless the context requires otherwise. The Condensed Consolidated Financial Statements have been prepared by us pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The unaudited interim Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for audited financial statements. The balance sheet as of June 30, 2022 was derived from the Company’s audited Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 but does not include all disclosures required by GAAP for audited financial statements. The unaudited interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal, recurring adjustments) necessary for a fair statement of the financial position, results of operations, comprehensive income, stockholders’ equity and cash flows for the periods indicated. These Condensed Consolidated Financial Statements and notes, however, should be read in conjunction with Item 8 “Financial Statements and Supplementary Data” included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. The Condensed Consolidated Financial Statements include the accounts of KLA and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The results of operations for the three and nine months ended March 31, 2023 are not necessarily indicative of the results that may be expected for any other interim period or for the full fiscal year ending June 30, 2023.
Management Estimates	Management Estimates. The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions in applying our accounting policies that affect the reported amounts of assets and liabilities (and related disclosure of contingent assets and liabilities) at the dates of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Recent Accounting Pronouncements and Recently Adopted	Recent Accounting Pronouncements Recently Adopted There have been no recently adopted updates. Updates Not Yet Effective In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.
Fair Value Measurements	Our financial assets and liabilities are measured and recorded at fair value, except for our debt and certain equity investments in privately held companies. Equity investments without a readily available fair value are accounted for using the measurement alternative. The measurement alternative is calculated as cost minus impairment, if any, plus or minus changes resulting from observable price changes. See Note 8 “Debt” to our Condensed Consolidated Financial Statements for disclosure of the fair value of our Senior Notes, as defined in that Note. Our non-financial assets, such as goodwill, intangible assets, and land, property and equipment, are assessed for impairment when an event or circumstance indicates that an other-than-temporary decline in value may have occurred.
Fair Value of Financial Instruments	Fair Value of Financial Instruments. We have evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts. The fair value of our cash equivalents, accounts receivable, accounts payable and other current assets and liabilities approximate their carrying amounts due to the relatively short maturity of these items. Fair Value Hierarchy. The authoritative guidance for fair value measurements establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below: Level 1 Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access. Level 2 Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 3 Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. There were no transfers between Level 1, Level 2 and Level 3 fair value measurements during the nine months ended March 31, 2023. The types of instruments valued based on quoted market prices in active markets include money market funds, certain U.S. Treasury securities, U.S. Government agency securities and equity securities. Such instruments are generally classified within Level 1 of the fair value hierarchy. The types of instruments valued based on other observable inputs include corporate debt securities, sovereign securities, municipal securities and certain U.S. Treasury securities. The market inputs used to value these instruments generally consist of market yields, reported trades and broker/dealer quotes. Such instruments are generally classified within Level 2 of the fair value hierarchy. The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-counter environment with a relatively high level of price transparency. The market participants generally are large financial institutions. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing intervals from public data sources and do not involve management judgment. These contracts are typically classified within Level 2 of the fair value hierarchy.

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Contract Balances	The following table represents the opening and closing balances of accounts receivable, net, contract assets and contract liabilities as of the indicated dates. As of As of (Dollar amounts in thousands) March 31, 2023 June 30, 2022 $ Change % Change Accounts receivable, net $ 1,940,067 $ 1,811,877 $ 128,190 7 % Contract assets $ 125,019 $ 114,747 $ 10,272 9 % Contract liabilities $ 1,074,445 $ 1,007,324 $ 67,121 7 %

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis	Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs As of March 31, 2023 (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Cash equivalents: Corporate debt securities $ 1,063 $ — $ 1,063 $ — Money market funds and other 1,080,003 1,080,003 — — Marketable securities: Corporate debt securities 460,142 — 460,142 — Municipal securities 35,884 — 35,884 — Sovereign securities 5,016 — 5,016 — U.S. Government agency securities 117,370 117,370 — — U.S. Treasury securities 424,723 389,126 35,597 — Equity securities 19,839 19,839 — — Total cash equivalents and marketable securities (1) 2,144,040 1,606,338 537,702 — Other current assets: Derivative assets 20,291 — 20,291 — Other non-current assets: Executive Deferred Savings Plan 245,090 192,854 52,236 — Total financial assets (1) $ 2,409,421 $ 1,799,192 $ 610,229 $ — Liabilities Derivative liabilities $ (13,196) $ — $ (13,196) $ — Contingent consideration payable (19,299) — — (19,299) Total financial liabilities $ (32,495) $ — $ (13,196) $ (19,299) ________________ (1) Excludes cash of $315.5 million held in operating accounts and time deposits of $430.7 million (of which $172.0 million were cash equivalents) as of March 31, 2023. Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the date indicated below, were presented on our Condensed Consolidated Balance Sheets as follows: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Little or No Market Activity Inputs As of June 30, 2022 (In thousands) Total (Level 1) (Level 2) (Level 3) Assets Cash equivalents: Corporate debt securities $ 922 $ — $ 922 $ — Money market funds and other 948,027 948,027 — — U.S. Treasury securities 22,485 — 22,485 — Marketable securities: Corporate debt securities 472,047 — 472,047 — Municipal securities 60,724 — 60,724 — Sovereign securities 5,990 — 5,990 — U.S. Government agency securities 91,116 91,116 — — U.S. Treasury securities 348,026 344,559 3,467 — Equity securities 11,035 11,035 — — Total cash equivalents and marketable securities (1) 1,960,372 1,394,737 565,635 — Other current assets: Derivative assets 40,311 — 40,311 — Other non-current assets: Executive Deferred Savings Plan 224,188 176,928 47,260 — Total financial assets (1) $ 2,224,871 $ 1,571,665 $ 653,206 $ — Liabilities Derivative liabilities $ (34,315) $ — $ (34,315) $ — Deferred payments (2,350) — — (2,350) Contingent consideration payable (23,674) — — (23,674) Total financial liabilities $ (60,339) $ — $ (34,315) $ (26,024) ________________ (1) Excludes cash of $472.8 million held in operating accounts and time deposits of $274.9 million (of which $140.7 million were cash equivalents) as of June 30, 2022.

FINANCIAL STATEMENT COMPONENTS

FINANCIAL STATEMENT COMPONENTS (Tables)	9 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Balance Sheet Components	Condensed Consolidated Balance Sheets As of As of (In thousands) March 31, 2023 June 30, 2022 Accounts receivable, net: Accounts receivable, gross $ 1,973,188 $ 1,832,508 Allowance for credit losses (33,121) (20,631) $ 1,940,067 $ 1,811,877 Inventories: Customer service parts $ 492,681 $ 402,121 Raw materials 1,503,024 1,042,916 Work-in-process 575,084 451,782 Finished goods 178,954 250,070 $ 2,749,743 $ 2,146,889 Other current assets: Contract assets $ 125,019 $ 114,747 Prepaid expenses 113,228 108,942 Deferred costs of revenues 112,074 124,487 Prepaid income and other taxes 37,834 89,713 Other current assets 50,576 64,248 $ 438,731 $ 502,137 Land, property and equipment, net: Land $ 72,286 $ 67,846 Buildings and leasehold improvements 810,173 712,751 Machinery and equipment 970,525 819,191 Office furniture and fixtures 57,554 44,957 Construction-in-process 147,932 110,079 2,058,470 1,754,824 Less: accumulated depreciation (1,074,199) (904,895) $ 984,271 $ 849,929 Other non-current assets: Executive Deferred Savings Plan (1) $ 245,090 $ 224,188 Operating lease right of use assets 201,014 126,444 Other non-current assets 171,806 133,980 $ 617,910 $ 484,612 Other current liabilities: Customer deposits $ 575,466 $ 394,016 Compensation and benefits 445,828 351,924 Income taxes payable 313,317 126,964 Executive Deferred Savings Plan (1) 245,734 225,867 Interest payable 56,049 39,683 Operating lease liabilities 33,522 32,218 Other liabilities and accrued expenses 439,535 374,367 $ 2,109,451 $ 1,545,039 Other non-current liabilities: Customer deposits $ 343,691 $ 204,914 Income taxes payable 317,263 367,052 Operating lease liabilities 137,811 81,369 Pension liabilities 75,716 78,525 Other non-current liabilities 127,497 150,782 $ 1,001,978 $ 882,642 ________________ (1) We have a non-qualified deferred compensation plan (known as “Executive Deferred Savings Plan” or “EDSP”) under which certain employees and non-employee directors may defer a portion of their compensation. The expense (benefit) associated with changes in the EDSP liability included in selling, general and administrative (“SG&A”) expense was $13.1 million and $(18.8) million in the three months ended March 31, 2023 and 2022, respectively, and was $14.7 million and $(7.8) million during the nine months ended March 31, 2023 and 2022, respectively. The amount of net gains (losses) associated with changes in the EDSP assets included in SG&A expense was $13.1 million and $(18.7) million in the three months ended March 31, 2023 and 2022, respectively, and was $14.7 million and $(8.0) million during the nine months ended March 31, 2023 and 2022, respectively. For additional details, refer to Note 1 “Description of Business and Summary of Significant Accounting Policies” to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.
Schedule of Components of Accumulated Other Comprehensive Income (Loss)	The components of Accumulated Other Comprehensive Income (Loss) (“AOCI”) as of the dates indicated below were as follows: (In thousands) Currency Translation Adjustments Unrealized Gains (Losses) on Available-for-Sale Securities Unrealized Gains (Losses) on Derivatives Unrealized Gains (Losses) on Defined Benefit Plans Total Balance as of March 31, 2023 $ (51,637) $ (10,934) $ 51,654 $ (24,374) $ (35,291) Balance as of June 30, 2022 $ (43,886) $ (15,486) $ 56,836 $ (24,935) $ (27,471)
Schedule of Reclassification out of Accumulated Other Comprehensive Income	The effects on net income of amounts reclassified from AOCI to the Condensed Consolidated Statements of Operations for the indicated periods were as follows (in thousands; amounts in parentheses indicate debits or reductions to earnings): AOCI Components Three Months Ended Nine Months Ended Location in the Condensed Consolidated Statement of Operations March 31, March 31, 2023 2022 2023 2022 Unrealized gains (losses) on cash flow hedges from foreign exchange and interest rate contracts Revenues $ 1,421 $ 1,600 $ 31,954 $ 4,868 Costs of revenues and operating expenses 467 (329) (8,804) (909) Interest expense 936 (279) 2,810 (837) Net gains reclassified from AOCI $ 2,824 $ 992 $ 25,960 $ 3,122 Unrealized gains (losses) on available-for-sale securities Other expense (income), net $ (250) $ (88) $ (831) $ (90)

MARKETABLE SECURITIES (Tables)

MARKETABLE SECURITIES (Tables)	9 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Unrealized Gain (Loss) on Investments	The amortized cost and fair value of marketable securities as of the dates indicated below were as follows: As of March 31, 2023 (In thousands) Amortized Gross Gross Fair Corporate debt securities $ 466,754 $ 473 $ (6,022) $ 461,205 Money market funds and other 1,080,003 — — 1,080,003 Municipal securities 36,660 — (776) 35,884 Sovereign securities 5,021 — (5) 5,016 U.S. Government agency securities 118,073 127 (830) 117,370 U.S. Treasury securities 431,619 466 (7,362) 424,723 Equity securities (1) 3,211 16,628 — 19,839 Subtotal 2,141,341 17,694 (14,995) 2,144,040 Add: Time deposits (2) 430,719 — — 430,719 Less: Cash equivalents 1,253,063 — — 1,253,063 Marketable securities $ 1,318,997 $ 17,694 $ (14,995) $ 1,321,696 As of June 30, 2022 (In thousands) Amortized Gross Gross Fair Corporate debt securities $ 481,881 $ 3 $ (8,915) $ 472,969 Money market funds and other 948,027 — — 948,027 Municipal securities 61,973 — (1,249) 60,724 Sovereign securities 6,041 2 (53) 5,990 U.S. Government agency securities 92,273 26 (1,183) 91,116 U.S. Treasury securities 378,871 18 (8,378) 370,511 Equity securities (1) 3,211 7,824 — 11,035 Subtotal 1,972,277 7,873 (19,778) 1,960,372 Add: Time deposits (2) 274,873 — — 274,873 Less: Cash equivalents 1,112,146 — (1) 1,112,145 Marketable securities $ 1,135,004 $ 7,873 $ (19,777) $ 1,123,100 ________________ (1) Unrealized gains on equity securities included in our portfolio include the initial fair value adjustment recorded upon a security becoming marketable. (2) Time deposits excluded from fair value measurements.
Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value	The following table summarizes the fair value and gross unrealized losses of our investments that were in an unrealized loss position as of the dates indicated below. As of March 31, 2023 Less than 12 Months 12 Months or Greater Total (In thousands) Fair Value Gross Fair Value Gross Fair Value Gross Corporate debt securities $ 163,334 $ (1,687) $ 221,831 $ (4,335) $ 385,165 $ (6,022) Municipal securities 8,711 (69) 27,173 (707) 35,884 (776) Sovereign securities 3,019 — 1,997 (5) 5,016 (5) U.S. Government agency securities 38,897 (125) 34,650 (705) 73,547 (830) U.S. Treasury securities 137,766 (1,945) 206,896 (5,417) 344,662 (7,362) Total $ 351,727 $ (3,826) $ 492,547 $ (11,169) $ 844,274 $ (14,995) As of June 30, 2022 (In thousands) Fair Value (1) Gross Unrealized Losses (1) Corporate debt securities $ 458,699 $ (8,915) Municipal securities 58,722 (1,249) Sovereign securities 2,963 (53) U.S. Government agency securities 60,285 (1,183) U.S. Treasury securities 336,819 (8,378) Total $ 917,488 $ (19,778) ________________ (1) As of June 30, 2022, our investments that were in a continuous loss position of 12 months or more, as well as the unrealized losses on those investments, were immaterial.
Schedule of Contractual Maturities of Securities	The contractual maturities of securities classified as available-for-sale, regardless of their classification on our Condensed Consolidated Balance Sheets, as of the date indicated below were as follows: As of March 31, 2023 (In thousands) Amortized Cost Fair Value Due within one year $ 836,765 $ 845,394 Due after one year through three years 482,232 476,302 Total $ 1,318,997 $ 1,321,696

GOODWILL AND PURCHASED INTANG_2

GOODWILL AND PURCHASED INTANGIBLE ASSETS (Tables)	9 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill Balances	The following table presents changes in goodwill carrying value during the nine months ended March 31, 2023: (In thousands) Wafer Inspection and Patterning Global Service and Support ( “ GSS ” ) Specialty Semiconductor Process Printed Circuit Board (“PCB”) and Display Component Inspection Total Balance as of June 30, 2022 $ 725,737 $ 25,908 $ 681,858 $ 872,971 $ 13,575 $ 2,320,049 Acquired goodwill 6,776 — — — — 6,776 Goodwill disposal from sale of business (1) — — — (42,622) — (42,622) Goodwill adjustments (5,337) — — — — (5,337) Foreign currency adjustments (49) — — — — (49) Balance as of March 31, 2023 $ 727,127 $ 25,908 $ 681,858 $ 830,349 $ 13,575 $ 2,278,817 (1) Refer to the “Business Dispositions” section of Note 6 “Business Combinations and Dispositions” for more information on the sale of Orbograph.
Schedule of Components of Purchased Intangible Assets	The components of purchased intangible assets as of the dates indicated below were as follows: (In thousands) As of March 31, 2023 As of June 30, 2022 Category Range of Useful Lives (in years) Gross Accumulated Net Gross Accumulated Net Existing technology 4-8 $ 1,536,826 $ 796,369 $ 740,457 $ 1,523,691 $ 668,175 $ 855,516 Customer relationships 4-9 358,567 195,461 163,106 366,567 167,819 198,748 Trade name / Trademark 4-7 116,583 75,043 41,540 121,083 68,194 52,889 Order backlog and other <1-7 85,836 76,337 9,499 87,836 58,970 28,866 Intangible assets subject to amortization (1) 2,097,812 1,143,210 954,602 2,099,177 963,158 1,136,019 In-process research and development 61,322 15,966 45,356 64,457 6,062 58,395 Total $ 2,159,134 $ 1,159,176 $ 999,958 $ 2,163,634 $ 969,220 $ 1,194,414 (1) The disposition of Orbograph during the three months ended September 30, 2022 resulted in a decrease in the gross amount of intangible assets subject to amortization of $34.5 million, a decrease in accumulated amortization of $15.9 million, and a decrease in the net amount of intangible assets of $18.6 million. Refer to the “Business Dispositions” section of Note 6 “Business Combinations and Dispositions” for more information on the sale of Orbograph.
Schedule of Amortization Expense for Purchased Intangible Assets	Amortization expense for purchased intangible assets for the periods indicated below was as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Amortization expense - Costs of revenues $ 45,446 $ 42,586 $ 135,958 $ 124,834 Amortization expense - SG&A 19,656 15,102 59,912 39,880 Amortization expense - Research and development 31 31 93 93 Total $ 65,133 $ 57,719 $ 195,963 $ 164,807
Schedule of Remaining Estimated Amortization Expense	Based on the purchased intangible assets gross carrying amount recorded as of March 31, 2023, the remaining estimated annual amortization expense is expected to be as follows: Fiscal year ending June 30: Amortization (In thousands) 2023 (remaining three months) $ 64,655 2024 238,575 2025 222,123 2026 206,211 2027 129,630 2028 and thereafter 93,408 Total $ 954,602

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The following table summarizes our debt as of March 31, 2023 and June 30, 2022: As of March 31, 2023 As of June 30, 2022 Amount Effective Amount Effective Fixed-rate 4.650% Senior Notes due on November 1, 2024 $ 750,000 4.682 % $ 1,250,000 4.682 % Fixed-rate 5.650% Senior Notes due on November 1, 2034 250,000 5.670 % 250,000 5.670 % Fixed-rate 4.100% Senior Notes due on March 15, 2029 800,000 4.159 % 800,000 4.159 % Fixed-rate 5.000% Senior Notes due on March 15, 2049 400,000 5.047 % 400,000 5.047 % Fixed-rate 3.300% Senior Notes due on March 1, 2050 750,000 3.302 % 750,000 3.302 % Fixed-rate 4.650% Senior Notes due on July 15, 2032 1,000,000 4.657 % 1,000,000 4.657 % Fixed-rate 4.950% Senior Notes due on July 15, 2052 1,200,000 5.009 % 1,200,000 5.009 % Fixed-rate 5.250% Senior Notes due on July 15, 2062 800,000 5.259 % 800,000 5.259 % Revolving Credit Facility — — % 275,000 2.258 % Total 5,950,000 6,725,000 Unamortized discount/premium, net (18,139) (19,304) Unamortized debt issuance costs (42,121) (44,978) Total $ 5,889,740 $ 6,660,718 Reported as: Long-term debt $ 5,889,740 $ 6,660,718 Total $ 5,889,740 $ 6,660,718

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Schedule of Leases Cost	Supplemental cash flow information related to leases was as follows: Nine Months Ended March 31, In thousands 2023 2022 Operating cash outflows from operating leases $ 29,630 $ 28,680 Right of use assets obtained in exchange for new operating lease liabilities $ 85,911 $ 20,698
Schedule of Maturities of Lease Liabilities	Maturities of lease liabilities as of March 31, 2023 were as follows: Fiscal Year Ending June 30: (In thousands) 2023 (remaining three months) $ 10,503 2024 33,605 2025 32,942 2026 26,363 2027 21,511 2028 and thereafter 72,457 Total lease payments 197,381 Less imputed interest (26,048) Total $ 171,333

EQUITY, LONG-TERM INCENTIVE C_2

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST (Tables)	9 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Combined Activity Under Equity Incentive Plans	The following table summarizes the combined activity under our equity incentive plans: (In thousands) Available For Grant (1) (2) Balance as of June 30, 2022 9,242 RSUs granted (3) (1,012) RSUs canceled 88 Balance as of March 31, 2023 8,318 __________________ (1) The number of RSUs reflects the application of the award multiplier of 2.0x to calculate the impact of the award on the shares reserved under the 2004 Plan. (2) No additional stock options, RSUs or other awards will be granted under the Assumed Equity Plans. (3) Includes RSUs granted to senior management during the nine months ended March 31, 2023 with performance-based vesting criteria (in addition to service-based vesting criteria for any of such RSUs that are deemed to have been earned) (“performance-based RSUs”). This line item includes all such performance-based RSUs granted during the nine months ended March 31, 2023 reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.6 million shares for the nine months ended March 31, 2023 reflects the application of the multiplier described above).
Schedule of Stock-based Compensation Expense	The following table shows stock-based compensation expense for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Stock-based compensation expense by: Costs of revenues $ 8,596 $ 6,543 $ 20,189 $ 14,475 R&D 13,289 8,482 30,437 18,077 SG&A 26,245 22,062 70,891 57,517 Total stock-based compensation expense $ 48,130 $ 37,087 $ 121,517 $ 90,069
Schedule of Restricted Stock Activity	The following table shows the activity and weighted-average grant date fair values for RSUs during the nine months ended March 31, 2023: Shares (1) (In thousands) Weighted-Average Outstanding RSUs as of June 30, 2022 (2) 1,593 $ 218.03 Granted (3) 506 $ 390.53 Vested and released (264) $ 147.65 Withheld for taxes (190) $ 147.65 Forfeited (45) $ 179.82 Outstanding RSUs as of March 31, 2023 (2) 1,600 $ 293.58 __________________ (1) Share numbers reflect actual shares subject to awarded RSUs. (2) Includes performance-based RSUs. (3) This line item includes performance-based RSUs granted during the nine months ended March 31, 2023 reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.3 million shares for the nine months ended March 31, 2023).
Schedule of Grant Date Fair Value, Weighted Average Grant Date Fair Value, and Tax Benefits for Restricted Stock Units	The following table shows the weighted-average grant date fair value per unit for the RSUs granted, aggregate grant date fair value of RSUs vested, and tax benefits realized by us in connection with vested and released RSUs for the indicated periods : Three Months Ended March 31, Nine Months Ended March 31, (In thousands, except for weighted-average grant date fair value) 2023 2022 2023 2022 Weighted-average grant date fair value per unit $ 409.77 $ 388.03 $ 390.53 $ 358.38 Grant date fair value of vested RSUs $ 9,217 $ 10,150 $ 67,152 $ 57,453 Tax benefits realized by us in connection with vested and released RSUs $ 4,517 $ 3,993 $ 17,368 $ 17,914
Schedule of Employee Stock Purchase Rights Valuation	The fair value of each purchase right under the ESPP was estimated on the date of grant using the Black-Scholes model and the straight-line attribution approach with the following weighted-average assumptions: Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Stock purchase plan: Expected stock price volatility 43.8 % 41.5 % 42.7 % 38.2 % Risk-free interest rate 3.9 % 0.1 % 2.5 % 0.1 % Dividend yield 1.4 % 1.0 % 1.6 % 1.2 % Expected life (in years) 0.5 0.5 0.5 0.5
Schedule of Tax Benefits Realized and Weighted-average fair value for the ESPP	The following table shows total cash received from employees for the issuance of shares under the ESPP, the number of shares purchased by employees through the ESPP, the tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP and the weighted-average fair value per share for the indicated periods: (In thousands, except for weighted-average fair value per share) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Total cash received from employees for the issuance of shares under the ESPP $ — $ — $ 33,793 $ 36,912 Number of shares purchased by employees through the ESPP — — 134 139 Tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP $ 616 $ 488 $ 1,540 $ 1,686 Weighted-average fair value per share based on Black-Scholes model $ 97.32 $ 107.45 $ 89.81 $ 94.91

STOCK REPURCHASE PROGRAM (Table

STOCK REPURCHASE PROGRAM (Tables)	9 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule of Share Repurchases	Share repurchases for the indicated periods (based on the trade date of the applicable repurchase) were as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Number of shares of common stock repurchased 1,227 1,539 4,913 3,833 Total cost of repurchases $ 482,712 $ 564,666 $ 943,310 $ 1,394,217

NET INCOME PER SHARE (Tables)

NET INCOME PER SHARE (Tables)	9 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Net Income per Share	The following table sets forth the computation of basic and diluted net income per share attributable to KLA: (In thousands, except per share amounts) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Numerator: Net income attributable to KLA $ 697,837 $ 730,572 $ 2,702,623 $ 2,516,433 Denominator: Weighted-average shares - basic, excluding unvested RSUs 137,865 150,145 140,349 151,250 Effect of dilutive RSUs and options 780 1,041 724 1,096 Weighted-average shares - diluted 138,645 151,186 141,073 152,346 Basic net income per share attributable to KLA $ 5.06 $ 4.87 $ 19.26 $ 16.64 Diluted net income per share attributable to KLA $ 5.03 $ 4.83 $ 19.16 $ 16.52 Anti-dilutive securities excluded from the computation of diluted net income per share 12 10 226 9

INCOME TAXES (Tables)

INCOME TAXES (Tables)	9 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Details of Income Taxes	The following table provides details of income taxes: Three Months Ended March 31, Nine Months Ended March 31, (Dollar amounts in thousands) 2023 2022 2023 2022 Income before income taxes $ 800,683 $ 846,285 $ 3,013,684 $ 2,539,538 Provision for income taxes $ 102,846 $ 115,625 $ 310,987 $ 22,876 Effective tax rate 12.8 % 13.7 % 10.3 % 0.9 %

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Receivables Sold Under Factoring Agreements	The following table shows total receivables sold under factoring agreements and proceeds from sales of LC for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Receivables sold under factoring agreements $ 107,140 $ 63,094 $ 288,599 $ 210,130 Proceeds from sales of LC $ — $ 74,267 $ 69,247 $ 115,433

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	9 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments, Location, Designated and Non-Designated, Gains (Losses)	The gains (losses) on derivatives in cash flow and net investment hedging relationships recognized in other comprehensive income for the indicated periods were as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Derivatives Designated as Cash Flow Hedging Instruments: Rate lock agreements: Amounts included in the assessment of effectiveness $ — $ 10,069 $ — $ 10,069 Foreign exchange contracts: Amounts included in the assessment of effectiveness $ 6,008 $ 7,733 $ 16,720 $ 15,335 Amounts excluded from the assessment of effectiveness $ 652 $ (25) $ (53) $ (34) Derivatives Designated as Net Investment Hedging Instruments: Foreign exchange contracts (1) : $ 154 $ 1,850 $ 1,986 $ 1,386 __________________ (1) No amounts were reclassified from AOCI into earnings related to the sale of a subsidiary, as there were no such sales during the periods presented. The locations and amounts of designated and non-designated derivatives’ gains and losses reported in the Condensed Consolidated Statements of Operations for the indicated periods were as follows: Three Months Ended March 31, Three Months Ended March 31, 2023 2022 (In thousands) Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Total amounts presented in the Condensed Consolidated Statements of Operations in which the effects of cash flow hedges are recorded $ 2,432,608 $ 1,572,015 $ 74,774 $ (14,864) $ 2,288,676 $ 1,393,769 $ 39,978 $ 8,644 Gains (Losses) on Derivatives Designated as Hedging Instruments: Rate lock agreements: Amount of gains (losses) reclassified from AOCI to earnings $ — $ — $ 936 $ — $ — $ — $ (279) $ — Foreign exchange contracts: Amount of gains (losses) reclassified from AOCI to earnings $ 1,748 $ 467 $ — $ — $ 1,711 $ (329) $ — $ — Amount excluded from the assessment of effectiveness recognized in earnings $ (327) $ — $ — $ 765 $ (111) $ — $ — $ 568 Gains (Losses) on Derivatives Not Designated as Hedging Instruments: Amount of gains (losses) recognized in earnings $ — $ — $ — $ (9,066) $ — $ — $ — $ (2,802) Nine Months Ended March 31, Nine Months Ended March 31, 2023 2022 (In thousands) Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Revenues Costs of Revenues and Operating Expenses Interest Expense Other Expense (Income), Net Total amounts presented in the Condensed Consolidated Statements of Operations in which the effects of cash flow hedges are recorded $ 8,140,919 $ 4,970,444 $ 223,449 $ (79,944) $ 6,725,144 $ 4,045,479 $ 116,142 $ 23,985 Gains (Losses) on Derivatives Designated as Hedging Instruments: Rate lock agreements: Amount of gains (losses) reclassified from AOCI to earnings $ — $ — $ 2,810 $ — $ — $ — $ (837) $ — Foreign exchange contracts: Amount of gains (losses) reclassified from AOCI to earnings $ 33,024 $ (8,804) $ — $ — $ 5,197 $ (909) $ — $ — Amount excluded from the assessment of effectiveness recognized in earnings $ (1,070) $ — $ — $ 1,675 $ (329) $ — $ — $ 1,883 Gains (Losses) on Derivatives Not Designated as Hedging Instruments: Amount of gains (losses) recognized in earnings $ — $ — $ — $ (2,773) $ — $ — $ — $ 4,261
Schedule of Notional Amounts of Derivatives Outstanding	The U.S. dollar equivalent of all outstanding notional amounts of foreign currency hedge contracts with maximum remaining maturities of approximately 14 months as of the dates indicated below, were as follows: As of As of (In thousands) March 31, 2023 June 30, 2022 Cash flow hedge contracts - foreign currency Purchase $ 192,875 $ 124,641 Sell $ 146,207 $ 176,259 Net investment hedge contracts - foreign currency Sell $ 87,157 $ 66,436 Other foreign currency hedge contracts Purchase $ 572,609 $ 565,586 Sell $ 296,379 $ 389,368
Schedule of Derivative Instruments, Fair Value	The locations and fair value of our derivatives reported in our Condensed Consolidated Balance Sheets as of the dates indicated below were as follows: Asset Derivatives Liability Derivatives Balance Sheet As of As of Balance Sheet As of As of Location March 31, 2023 June 30, 2022 Location March 31, 2023 June 30, 2022 (In thousands) Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts Other current assets $ 15,192 $ 20,595 Other current liabilities $ (1,504) $ 8,406 Total derivatives designated as hedging instruments 15,192 20,595 (1,504) 8,406 Derivatives not designated as hedging instruments Foreign exchange contracts Other current assets 5,099 19,716 Other current liabilities (11,692) 25,909 Total derivatives not designated as hedging instruments 5,099 19,716 (11,692) 25,909 Total derivatives $ 20,291 $ 40,311 $ (13,196) $ 34,315
Schedule of Balances and Changes in Accumulated Other Comprehensive Income Related to Derivative Instruments	The changes in AOCI, before taxes, related to derivatives for the indicated periods were as follows: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Beginning AOCI $ 65,721 $ (20,831) $ 77,018 $ (25,830) Amount reclassified to earnings as net (gains) losses (2,824) (992) (25,960) (3,122) Net change in unrealized gains (losses) 6,814 19,627 18,653 26,756 Ending AOCI $ 69,711 $ (2,196) $ 69,711 $ (2,196)
Schedule of Offsetting Derivative Assets	The information related to the offsetting arrangements for the periods indicated was as follows: As of March 31, 2023 Gross Amounts of Derivatives Not Offset in the Condensed Consolidated Balance Sheets (In thousands) Gross Amounts of Derivatives Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets Financial Instruments Cash Collateral Received Net Amount Derivatives - assets $ 20,291 $ — $ 20,291 $ (10,113) $ — $ 10,178 Derivatives - liabilities $ (13,196) $ — $ (13,196) $ 10,113 $ — $ (3,083) As of June 30, 2022 Gross Amounts of Derivatives Not Offset in the Condensed Consolidated Balance Sheets (In thousands) Gross Amounts of Derivatives Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets Financial Instruments Cash Collateral Received Net Amount Derivatives - assets $ 40,311 $ — $ 40,311 $ (12,291) $ — $ 28,020 Derivatives - liabilities $ (34,315) $ — $ (34,315) $ 12,291 $ — $ (22,024)
Schedule of Offsetting Derivative Liabilities	The information related to the offsetting arrangements for the periods indicated was as follows: As of March 31, 2023 Gross Amounts of Derivatives Not Offset in the Condensed Consolidated Balance Sheets (In thousands) Gross Amounts of Derivatives Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets Financial Instruments Cash Collateral Received Net Amount Derivatives - assets $ 20,291 $ — $ 20,291 $ (10,113) $ — $ 10,178 Derivatives - liabilities $ (13,196) $ — $ (13,196) $ 10,113 $ — $ (3,083) As of June 30, 2022 Gross Amounts of Derivatives Not Offset in the Condensed Consolidated Balance Sheets (In thousands) Gross Amounts of Derivatives Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets Financial Instruments Cash Collateral Received Net Amount Derivatives - assets $ 40,311 $ — $ 40,311 $ (12,291) $ — $ 28,020 Derivatives - liabilities $ (34,315) $ — $ (34,315) $ 12,291 $ — $ (22,024)

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	9 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following table provides the transactions with these parties for the indicated periods (for the portion of such period that they were considered related): Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Total revenues $ 6,251 $ 4,485 $ 18,050 $ 5,108 Total purchases $ 462 $ 562 $ 3,742 $ 834

SEGMENT REPORTING AND GEOGRAP_2

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION (Tables)	9 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of Results for Reportable Segments	The following is a summary of results for each of our three reportable segments for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Semiconductor Process Control: Revenues $ 2,171,557 $ 1,979,295 $ 7,226,711 $ 5,810,580 Segment gross profit 1,367,886 1,284,450 4,622,905 3,789,316 Specialty Semiconductor Process: Revenues 128,438 117,253 414,390 332,020 Segment gross profit 65,328 61,521 216,408 176,516 PCB, Display and Component Inspection: Revenues 131,923 192,533 502,627 583,318 Segment gross profit 43,361 93,298 182,899 270,096 Totals: Revenues for reportable segments $ 2,431,918 $ 2,289,081 $ 8,143,728 $ 6,725,918 Segment gross profit $ 1,476,575 $ 1,439,269 $ 5,022,212 $ 4,235,928
Schedule of Reconciliation of Total Reportable Segments Revenue to Total Revenue	The following table reconciles total revenues for reportable segments to total revenues for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Total revenues for reportable segments $ 2,431,918 $ 2,289,081 $ 8,143,728 $ 6,725,918 Corporate allocations and effects of changes in foreign currency exchange rates 690 (405) (2,809) (774) Total revenues $ 2,432,608 $ 2,288,676 $ 8,140,919 $ 6,725,144
Schedule of Reconciliation of Total Segment Gross Profit to Income Before Income Taxes	The following table reconciles total segment gross profit to income before income taxes for the indicated periods: Three Months Ended March 31, Nine Months Ended March 31, (In thousands) 2023 2022 2023 2022 Total segment gross profit $ 1,476,575 $ 1,439,269 $ 5,022,212 $ 4,235,928 Acquisition-related charges, corporate allocations, and effects of changes in foreign currency exchange rates (1) 49,313 42,684 136,651 124,661 R&D 328,276 285,189 979,617 808,373 SG&A 238,393 216,489 735,469 623,229 Interest expense 74,774 39,978 223,449 116,142 Loss on extinguishment of debt — — 13,286 — Other expense (income), net (14,864) 8,644 (79,944) 23,985 Income before income taxes $ 800,683 $ 846,285 $ 3,013,684 $ 2,539,538 __________________
Schedule of Revenues by Geographic Region	The following is a summary of revenues by geographic region, based on ship-to location, for the indicated periods: (Dollar amounts in thousands) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Revenues: China $ 635,018 26 % $ 709,502 31 % $ 2,156,380 26 % $ 1,939,195 29 % Taiwan 478,855 20 % 515,097 22 % 1,996,188 24 % 1,918,623 29 % Korea 468,226 19 % 474,019 21 % 1,466,624 18 % 1,036,297 16 % North America 341,376 14 % 219,267 10 % 941,771 12 % 668,601 10 % Japan 215,531 9 % 132,829 6 % 702,986 9 % 504,278 7 % Europe and Israel 209,136 9 % 164,246 7 % 542,823 7 % 426,881 6 % Rest of Asia 84,466 3 % 73,716 3 % 334,147 4 % 231,269 3 % Total $ 2,432,608 100 % $ 2,288,676 100 % $ 8,140,919 100 % $ 6,725,144 100 %
Schedule of Revenues by Major Products	The following is a summary of revenues by major product categories for the indicated periods: (Dollar amounts in thousands) Three Months Ended March 31, Nine Months Ended March 31, 2023 2022 2023 2022 Revenues: Wafer Inspection $ 1,027,191 42 % $ 919,072 40 % $ 3,386,273 42 % $ 2,910,616 43 % Patterning 611,631 25 % 610,821 27 % 2,206,263 27 % 1,559,197 23 % Specialty Semiconductor Process 114,896 5 % 105,832 5 % 374,882 5 % 303,884 5 % PCB, Display and Component Inspection 69,495 3 % 123,384 5 % 312,582 4 % 383,021 6 % Services 529,124 22 % 488,017 21 % 1,578,418 19 % 1,398,828 21 % Other 80,271 3 % 41,550 2 % 282,501 3 % 169,598 2 % Total $ 2,432,608 100 % $ 2,288,676 100 % $ 8,140,919 100 % $ 6,725,144 100 %
Schedule of Long-Lived Assets by Geographic Region	Land, property and equipment, net by geographic region as of the dates indicated below were as follows: As of As of (In thousands) March 31, 2023 June 30, 2022 Land, property and equipment, net: United States $ 644,799 $ 547,454 Singapore 152,275 146,057 Israel 88,277 72,791 Europe 60,827 55,370 Rest of Asia 38,093 28,257 Total $ 984,271 $ 849,929

REVENUE - Schedule of Contract

REVENUE - Schedule of Contract Balances (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Accounts receivable, net
Accounts receivable, net	$ 1,940,067	$ 1,811,877
Change in accounts receivable, net	$ 128,190
Percentage change in accounts receivable, net	7%
Contract assets
Contract assets	$ 125,019	114,747
Change in contract assets	$ 10,272
Percentage change in contract assets	9%
Contract liabilities
Contract liabilities	$ 1,074,445	$ 1,007,324
Change in contract liabilities	$ 67,121
Percentage change in contract liabilities	7%

REVENUE - Additional Informatio

REVENUE - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue remainder payable acceptance period	30 days
Revenue recognized in excess of amount billed to customer	$ 96.9
Decrease in contract assets, reclassified to accounts receivable	86.9
Change in contract liabilities, revenue recognized	$ 753.1	$ 495.8
Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue payment terms required payment percentage of total contract consideration within 30 To 60 days of shipment	70%
Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue payment terms required payment percentage of total contract consideration within 30 To 60 days of shipment	90%

REVENUE - Remaining Performance

REVENUE - Remaining Performance Obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Remaining performance obligation	$ 11,940,000
Customer deposits	919,200
Contract liabilities	$ 1,074,445	$ 1,007,324
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, expected timing of satisfaction, period	12 months
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	45%
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	55%

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Other current assets:
Derivative assets	$ 20,291	$ 40,311
Liabilities
Derivative liabilities	(13,196)	(34,315)
Contingent consideration payable	(19,300)
Cash excluded from fair value measurement	315,500	472,800
Time deposits excluded from fair value measurement	430,700	274,900
Time deposits, cash equivalents excluded from fair value measurement	172,000	140,700
Recurring
Marketable securities:
Total cash equivalents and marketable securities	2,144,040	1,960,372
Other current assets:
Derivative assets	20,291	40,311
Other non-current assets:
Executive Deferred Savings Plan	245,090	224,188
Total financial assets	2,409,421	2,224,871
Liabilities
Derivative liabilities	(13,196)	(34,315)
Deferred payments		(2,350)
Contingent consideration payable	(19,299)	(23,674)
Total financial liabilities	(32,495)	(60,339)
Recurring | Corporate debt securities
Cash equivalents:
Cash equivalents	1,063	922
Marketable securities:
Marketable securities	460,142	472,047
Recurring | Money market funds and other
Cash equivalents:
Cash equivalents	1,080,003	948,027
Recurring | Municipal securities
Marketable securities:
Marketable securities	35,884	60,724
Recurring | Sovereign securities
Marketable securities:
Marketable securities	5,016	5,990
Recurring | U.S. Government agency securities
Marketable securities:
Marketable securities	117,370	91,116
Recurring | U.S. Treasury securities
Cash equivalents:
Cash equivalents		22,485
Marketable securities:
Marketable securities	424,723	348,026
Recurring | Equity securities
Marketable securities:
Marketable securities	19,839	11,035
Recurring | Level 1
Marketable securities:
Total cash equivalents and marketable securities	1,606,338	1,394,737
Other current assets:
Derivative assets	0	0
Other non-current assets:
Executive Deferred Savings Plan	192,854	176,928
Total financial assets	1,799,192	1,571,665
Liabilities
Derivative liabilities	0	0
Deferred payments		0
Contingent consideration payable	0	0
Total financial liabilities	0	0
Recurring | Level 1 | Corporate debt securities
Cash equivalents:
Cash equivalents	0	0
Marketable securities:
Marketable securities	0	0
Recurring | Level 1 | Money market funds and other
Cash equivalents:
Cash equivalents	1,080,003	948,027
Recurring | Level 1 | Municipal securities
Marketable securities:
Marketable securities	0	0
Recurring | Level 1 | Sovereign securities
Marketable securities:
Marketable securities	0	0
Recurring | Level 1 | U.S. Government agency securities
Marketable securities:
Marketable securities	117,370	91,116
Recurring | Level 1 | U.S. Treasury securities
Cash equivalents:
Cash equivalents		0
Marketable securities:
Marketable securities	389,126	344,559
Recurring | Level 1 | Equity securities
Marketable securities:
Marketable securities	19,839	11,035
Recurring | Level 2
Marketable securities:
Total cash equivalents and marketable securities	537,702	565,635
Other current assets:
Derivative assets	20,291	40,311
Other non-current assets:
Executive Deferred Savings Plan	52,236	47,260
Total financial assets	610,229	653,206
Liabilities
Derivative liabilities	(13,196)	(34,315)
Deferred payments		0
Contingent consideration payable	0	0
Total financial liabilities	(13,196)	(34,315)
Recurring | Level 2 | Corporate debt securities
Cash equivalents:
Cash equivalents	1,063	922
Marketable securities:
Marketable securities	460,142	472,047
Recurring | Level 2 | Money market funds and other
Cash equivalents:
Cash equivalents	0	0
Recurring | Level 2 | Municipal securities
Marketable securities:
Marketable securities	35,884	60,724
Recurring | Level 2 | Sovereign securities
Marketable securities:
Marketable securities	5,016	5,990
Recurring | Level 2 | U.S. Government agency securities
Marketable securities:
Marketable securities	0	0
Recurring | Level 2 | U.S. Treasury securities
Cash equivalents:
Cash equivalents		22,485
Marketable securities:
Marketable securities	35,597	3,467
Recurring | Level 2 | Equity securities
Marketable securities:
Marketable securities	0	0
Recurring | Level 3
Marketable securities:
Total cash equivalents and marketable securities	0	0
Other current assets:
Derivative assets	0	0
Other non-current assets:
Executive Deferred Savings Plan	0	0
Total financial assets	0	0
Liabilities
Derivative liabilities	0	0
Deferred payments		(2,350)
Contingent consideration payable	(19,299)	(23,674)
Total financial liabilities	(19,299)	(26,024)
Recurring | Level 3 | Corporate debt securities
Cash equivalents:
Cash equivalents	0	0
Marketable securities:
Marketable securities	0	0
Recurring | Level 3 | Money market funds and other
Cash equivalents:
Cash equivalents	0	0
Recurring | Level 3 | Municipal securities
Marketable securities:
Marketable securities	0	0
Recurring | Level 3 | Sovereign securities
Marketable securities:
Marketable securities	0	0
Recurring | Level 3 | U.S. Government agency securities
Marketable securities:
Marketable securities	0	0
Recurring | Level 3 | U.S. Treasury securities
Cash equivalents:
Cash equivalents		0
Marketable securities:
Marketable securities	0	0
Recurring | Level 3 | Equity securities
Marketable securities:
Marketable securities	$ 0	$ 0

FINANCIAL STATEMENT COMPONENT_2

FINANCIAL STATEMENT COMPONENTS - Balance Sheet Components (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Accounts receivable, net:
Accounts receivable, gross	$ 1,973,188		$ 1,973,188		$ 1,832,508
Allowance for credit losses	(33,121)		(33,121)		(20,631)
Accounts receivable, net	1,940,067		1,940,067		1,811,877
Inventories:
Customer service parts	492,681		492,681		402,121
Raw materials	1,503,024		1,503,024		1,042,916
Work-in-process	575,084		575,084		451,782
Finished goods	178,954		178,954		250,070
Inventories	2,749,743		2,749,743		2,146,889
Other current assets:
Contract assets	125,019		125,019		114,747
Prepaid expenses	113,228		113,228		108,942
Deferred costs of revenues	112,074		112,074		124,487
Prepaid income and other taxes	37,834		37,834		89,713
Other current assets	50,576		50,576		64,248
Other current assets, total	438,731		438,731		502,137
Land, property and equipment, net:
Land	72,286		72,286		67,846
Buildings and leasehold improvements	810,173		810,173		712,751
Machinery and equipment	970,525		970,525		819,191
Office furniture and fixtures	57,554		57,554		44,957
Construction-in-process	147,932		147,932		110,079
Land, property and equipment, gross	2,058,470		2,058,470		1,754,824
Less: accumulated depreciation	(1,074,199)		(1,074,199)		(904,895)
Land, property and equipment, net	984,271		984,271		849,929
Other non-current assets:
Executive Deferred Savings Plan	245,090		245,090		224,188
Operating lease right of use assets	201,014		201,014		126,444
Other non-current assets	171,806		171,806		133,980
Other non-current assets, total	617,910		617,910		484,612
Other current liabilities:
Customer deposits	575,466		575,466		394,016
Compensation and benefits	445,828		445,828		351,924
Income taxes payable	313,317		313,317		126,964
Executive Deferred Savings Plan	245,734		245,734		225,867
Interest payable	56,049		56,049		39,683
Operating lease liabilities	$ 33,522		$ 33,522		$ 32,218
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities, total		Other current liabilities, total		Other current liabilities, total
Other liabilities and accrued expenses	$ 439,535		$ 439,535		$ 374,367
Other current liabilities, total	2,109,451		2,109,451		1,545,039
Other non-current liabilities:
Customer deposits	343,691		343,691		204,914
Income taxes payable	317,263		317,263		367,052
Operating lease liabilities	137,811		137,811		81,369
Pension liabilities	75,716		75,716		78,525
Other non-current liabilities	$ 127,497		$ 127,497		$ 150,782
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities, total		Other non-current liabilities, total		Other non-current liabilities, total
Other non-current liabilities, total	$ 1,001,978		$ 1,001,978		$ 882,642
SG&A
Other non-current liabilities:
Expense associated with changes in the EDSP liability	13,100	$ (18,800)	14,700	$ (7,800)
Gain on deferred compensation plan assets	$ 13,100	$ (18,700)	$ 14,700	$ (8,000)

FINANCIAL STATEMENT COMPONENT_3

FINANCIAL STATEMENT COMPONENTS - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ 1,401,351
Ending balance	$ 2,682,781
Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(43,886)
Ending balance	(51,637)
Unrealized Gains (Losses) on Available-for-Sale Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(15,486)
Ending balance	(10,934)
Unrealized Gains (Losses) on Derivatives
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		56,836
Ending balance	51,654
Unrealized Gains (Losses) on Defined Benefit Plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(24,935)
Ending balance	(24,374)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (27,471)
Ending balance	$ (35,291)

FINANCIAL STATEMENT COMPONENT_4

FINANCIAL STATEMENT COMPONENTS - Effects on Net Income (Loss) of Amounts Reclassified from AOCI (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss)
Revenues	$ 2,432,608			$ 2,288,676			$ 8,140,919	$ 6,725,144
Costs of revenues and operating expenses	(1,572,015)			(1,393,769)			(4,970,444)	(4,045,479)
Interest expense	(74,774)			(39,978)			(223,449)	(116,142)
Net gains reclassified from AOCI	697,837	$ 978,795	$ 1,025,991	730,572	$ 717,444	$ 1,068,417	2,702,623	2,516,433
Other expense (income), net	(14,864)			8,644			(79,944)	23,985
Unrealized Gains (Losses) on Defined Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Reclassification adjustment from AOCI, net of tax	400			400			1,200	1,100
Reclassification out of accumulated other comprehensive income | Unrealized gains (losses) on cash flow hedges from foreign exchange and interest rate contracts
Accumulated Other Comprehensive Income (Loss)
Revenues	1,421			1,600			31,954	4,868
Costs of revenues and operating expenses	467			(329)			(8,804)	(909)
Interest expense	936			(279)			2,810	(837)
Net gains reclassified from AOCI	2,824			992			25,960	3,122
Reclassification out of accumulated other comprehensive income | Unrealized gains (losses) on available-for-sale securities
Accumulated Other Comprehensive Income (Loss)
Other expense (income), net	$ (250)			$ (88)			$ (831)	$ (90)

MARKETABLE SECURITIES - Amortiz

MARKETABLE SECURITIES - Amortized Cost and Fair Value (Details) $ in Thousands	Mar. 31, 2023 USD ($) investment	Jun. 30, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, fair value	$ 1,321,696
Money market funds and other	1,080,003	$ 948,027
Equity securities, amortized cost	3,211	3,211
Equity securities, gross unrealized gains	16,628	7,824
Equity securities, gross unrealized losses	0	0
Equity securities, fair value	19,839	11,035
Subtotal, amortized cost	2,141,341	1,972,277
Subtotal, gross unrealized gains	17,694	7,873
Subtotal, gross unrealized losses	(14,995)	(19,778)
Subtotal, fair value	2,144,040	1,960,372
Add: Time deposits	430,719	274,873
Cash equivalents, amortized cost	1,253,063	1,112,146
Cash equivalents, gross unrealized gains	0	0
Cash equivalents, gross unrealized losses	0	(1)
Cash equivalents, fair value	1,253,063	1,112,145
Marketable securities, amortized cost	1,318,997	1,135,004
Marketable securities, gross unrealized gains	17,694	7,873
Marketable securities, gross unrealized losses	(14,995)	(19,777)
Marketable securities, fair value	$ 1,321,696	1,123,100
Number of investments in an unrealized loss position | investment	440
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 466,754	481,881
Available-for-sale securities, gross unrealized gains	473	3
Available-for-sale securities, gross unrealized losses	(6,022)	(8,915)
Available-for-sale securities, fair value	461,205	472,969
Municipal securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	36,660	61,973
Available-for-sale securities, gross unrealized gains	0	0
Available-for-sale securities, gross unrealized losses	(776)	(1,249)
Available-for-sale securities, fair value	35,884	60,724
Sovereign securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	5,021	6,041
Available-for-sale securities, gross unrealized gains	0	2
Available-for-sale securities, gross unrealized losses	(5)	(53)
Available-for-sale securities, fair value	5,016	5,990
U.S. Government agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	118,073	92,273
Available-for-sale securities, gross unrealized gains	127	26
Available-for-sale securities, gross unrealized losses	(830)	(1,183)
Available-for-sale securities, fair value	117,370	91,116
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	431,619	378,871
Available-for-sale securities, gross unrealized gains	466	18
Available-for-sale securities, gross unrealized losses	(7,362)	(8,378)
Available-for-sale securities, fair value	$ 424,723	$ 370,511
Corporate and Government securities
Debt Securities, Available-for-sale [Line Items]
Investment portfolio, maximum maturity term	3 years

MARKETABLE SECURITIES - Continu

MARKETABLE SECURITIES - Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	$ 351,727
Less than 12 Months, Gross Unrealized Losses	(3,826)
12 Months or Greater, Fair Value	492,547
12 Months or Greater, Gross Unrealized Losses	(11,169)
Fair Value	844,274	$ 917,488
Gross Unrealized Losses	(14,995)	(19,778)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	163,334
Less than 12 Months, Gross Unrealized Losses	(1,687)
12 Months or Greater, Fair Value	221,831
12 Months or Greater, Gross Unrealized Losses	(4,335)
Fair Value	385,165	458,699
Gross Unrealized Losses	(6,022)	(8,915)
Municipal securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	8,711
Less than 12 Months, Gross Unrealized Losses	(69)
12 Months or Greater, Fair Value	27,173
12 Months or Greater, Gross Unrealized Losses	(707)
Fair Value	35,884	58,722
Gross Unrealized Losses	(776)	(1,249)
Sovereign securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	3,019
Less than 12 Months, Gross Unrealized Losses	0
12 Months or Greater, Fair Value	1,997
12 Months or Greater, Gross Unrealized Losses	(5)
Fair Value	5,016	2,963
Gross Unrealized Losses	(5)	(53)
U.S. Government agency securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	38,897
Less than 12 Months, Gross Unrealized Losses	(125)
12 Months or Greater, Fair Value	34,650
12 Months or Greater, Gross Unrealized Losses	(705)
Fair Value	73,547	60,285
Gross Unrealized Losses	(830)	(1,183)
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	137,766
Less than 12 Months, Gross Unrealized Losses	(1,945)
12 Months or Greater, Fair Value	206,896
12 Months or Greater, Gross Unrealized Losses	(5,417)
Fair Value	344,662	336,819
Gross Unrealized Losses	$ (7,362)	$ (8,378)

MARKETABLE SECURITIES - Contrac

MARKETABLE SECURITIES - Contractual Maturities (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Amortized Cost
Due within one year	$ 836,765
Due after one year through three years	482,232
Amortized Cost	1,318,997
Fair Value
Due within one year	845,394
Due after one year through three years	476,302
Fair Value	$ 1,321,696

BUSINESS COMBINATIONS AND DIS_2

BUSINESS COMBINATIONS AND DISPOSITIONS - Business Combinations (Details) - USD ($) $ in Thousands				9 Months Ended
	Aug. 09, 2022	May 01, 2022	Feb. 28, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Business Acquisition
Total purchase consideration, paid in cash				$ 27,144	$ 470,887
Goodwill				2,278,817		$ 2,320,049
Contingent consideration				$ 19,300
August 9, 2022 Acquisition
Business Acquisition
Total purchase consideration, paid in cash	$ 32,700
Identifiable intangible assets acquired	30,000
Net tangible assets acquired	2,300
Deferred tax liabilities assumed	6,500
Goodwill	$ 6,800
May 1, 2022 Acquisition
Business Acquisition
Total purchase consideration, paid in cash		$ 8,600
ECI Technology, Inc
Business Acquisition
Total purchase consideration, paid in cash			$ 431,500
Identifiable intangible assets acquired			208,400
Deferred tax liabilities assumed			40,500
Goodwill			$ 266,400
Percentage of outstanding shares acquired			100%
Net tangible liabilities assumed			$ 2,900

BUSINESS COMBINATIONS AND DIS_3

BUSINESS COMBINATIONS AND DISPOSITIONS - Business Dispositions (Details) - USD ($) $ in Thousands		9 Months Ended
	Aug. 11, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Schedule of Equity Method Investments [Line Items]
Gain on sale of business		$ 29,687	$ 0
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Orbograph
Schedule of Equity Method Investments [Line Items]
Consideration from sale of business	$ 110,000
Net cash proceeds from disposition	75,400
Gain on sale of business	29,700
Tangible assets disposed	26,500
Liabilities disposed	30,500
Goodwill and intangible assets disposed	$ 61,200
Orbograph
Schedule of Equity Method Investments [Line Items]
Non-controlling interest, ownership				94%

GOODWILL AND PURCHASED INTANG_3

GOODWILL AND PURCHASED INTANGIBLE ASSETS - Additional Information (Details)	9 Months Ended
	Mar. 31, 2023 USD ($) segment
Goodwill and Intangible Assets Disclosure [Abstract]
Number of reportable segments | segment	3
Number of operating segments | segment	5
Goodwill impairment | $	$ 0
Impairment of intangible assets, purchased | $	$ 0

GOODWILL AND PURCHASED INTANG_4

GOODWILL AND PURCHASED INTANGIBLE ASSETS - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 2,320,049
Acquired goodwill	6,776
Goodwill disposal from sale of business	(42,622)
Goodwill adjustments	(5,337)
Foreign currency adjustments	(49)
Ending balance	2,278,817
Wafer Inspection and Patterning
Goodwill [Roll Forward]
Beginning balance	725,737
Acquired goodwill	6,776
Goodwill disposal from sale of business	0
Goodwill adjustments	(5,337)
Foreign currency adjustments	(49)
Ending balance	727,127
Global Service and Support (“GSS”)
Goodwill [Roll Forward]
Beginning balance	25,908
Acquired goodwill	0
Goodwill disposal from sale of business	0
Goodwill adjustments	0
Foreign currency adjustments	0
Ending balance	25,908
Specialty Semiconductor Process
Goodwill [Roll Forward]
Beginning balance	681,858
Acquired goodwill	0
Goodwill disposal from sale of business	0
Goodwill adjustments	0
Foreign currency adjustments	0
Ending balance	681,858
Printed Circuit Board (“PCB”) and Display
Goodwill [Roll Forward]
Beginning balance	872,971
Acquired goodwill	0
Goodwill disposal from sale of business	(42,622)
Goodwill adjustments	0
Foreign currency adjustments	0
Ending balance	830,349
Component Inspection
Goodwill [Roll Forward]
Beginning balance	13,575
Acquired goodwill	0
Goodwill disposal from sale of business	0
Goodwill adjustments	0
Foreign currency adjustments	0
Ending balance	$ 13,575

GOODWILL AND PURCHASED INTANG_5

GOODWILL AND PURCHASED INTANGIBLE ASSETS - Purchased Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Aug. 11, 2022	Jun. 30, 2022
Purchased Intangible Assets
Intangible assets subject to amortization, gross	$ 2,097,812		$ 2,099,177
Intangible assets, gross	2,159,134		2,163,634
Intangible assets subject to amortization, accumulated amortization and impairment	1,143,210		963,158
Accumulated Amortization and Impairment	1,159,176		969,220
Total	954,602		1,136,019
Purchased intangible assets, net	999,958		1,194,414
Orbograph | Disposal Group, Disposed of by Sale, Not Discontinued Operations
Purchased Intangible Assets
Intangible assets subject to amortization, gross		$ 34,500
Intangible assets subject to amortization, accumulated amortization and impairment		15,900
Total		$ 18,600
In-process research and development
Purchased Intangible Assets
Indefinite-lived intangible assets, gross	61,322		64,457
Indefinite-lived intangible assets, other accumulated adjustments	15,966		6,062
Indefinite-lived intangible assets, net	45,356		58,395
Existing technology
Purchased Intangible Assets
Intangible assets subject to amortization, gross	1,536,826		1,523,691
Intangible assets subject to amortization, accumulated amortization and impairment	796,369		668,175
Total	740,457		855,516
Customer relationships
Purchased Intangible Assets
Intangible assets subject to amortization, gross	358,567		366,567
Intangible assets subject to amortization, accumulated amortization and impairment	195,461		167,819
Total	163,106		198,748
Trade name / Trademark
Purchased Intangible Assets
Intangible assets subject to amortization, gross	116,583		121,083
Intangible assets subject to amortization, accumulated amortization and impairment	75,043		68,194
Total	41,540		52,889
Order backlog and other
Purchased Intangible Assets
Intangible assets subject to amortization, gross	85,836		87,836
Intangible assets subject to amortization, accumulated amortization and impairment	76,337		58,970
Total	$ 9,499		$ 28,866
Minimum | Existing technology
Purchased Intangible Assets
Range of Useful  Lives (in years)	4 years
Minimum | Customer relationships
Purchased Intangible Assets
Range of Useful  Lives (in years)	4 years
Minimum | Trade name / Trademark
Purchased Intangible Assets
Range of Useful  Lives (in years)	4 years
Minimum | Order backlog and other
Purchased Intangible Assets
Range of Useful  Lives (in years)	1 year
Maximum | Existing technology
Purchased Intangible Assets
Range of Useful  Lives (in years)	8 years
Maximum | Customer relationships
Purchased Intangible Assets
Range of Useful  Lives (in years)	9 years
Maximum | Trade name / Trademark
Purchased Intangible Assets
Range of Useful  Lives (in years)	7 years
Maximum | Order backlog and other
Purchased Intangible Assets
Range of Useful  Lives (in years)	7 years

GOODWILL AND PURCHASED INTANG_6

GOODWILL AND PURCHASED INTANGIBLE ASSETS - Amortization Expense for Purchased Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Purchased Intangible Assets
Amortization of intangible assets	$ 65,133	$ 57,719	$ 195,963	$ 164,807
Amortization expense - Costs of revenues
Purchased Intangible Assets
Amortization of intangible assets	45,446	42,586	135,958	124,834
Amortization expense - SG&A
Purchased Intangible Assets
Amortization of intangible assets	19,656	15,102	59,912	39,880
Amortization expense - Research and development
Purchased Intangible Assets
Amortization of intangible assets	$ 31	$ 31	$ 93	$ 93

GOODWILL AND PURCHASED INTANG_7

GOODWILL AND PURCHASED INTANGIBLE ASSETS - Future Estimated Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Remaing Estimated Amortization Expense
2023 (remaining three months)	$ 64,655
2024	238,575
2025	222,123
2026	206,211
2027	129,630
2028 and thereafter	93,408
Total	$ 954,602	$ 1,136,019

DEBT - Schedule of Debt (Detail

DEBT - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Debt Instrument
Total	$ 5,950,000	$ 6,725,000
Unamortized discount/premium, net	(18,139)	(19,304)
Unamortized debt issuance costs	(42,121)	(44,978)
Total	5,889,740	6,660,718
Long-term debt	5,889,740	6,660,718
Line of credit | Revolving Credit Facility
Debt Instrument
Debt outstanding	$ 0	$ 275,000
Effective interest rate	0%	2.258%
Fixed-rate 4.650% Senior Notes due on November 1, 2024 | Senior notes
Debt Instrument
Stated interest rate	4.65%
Debt outstanding	$ 750,000	$ 1,250,000
Effective interest rate	4.682%	4.682%
Fixed-rate 5.650% Senior Notes due on November 1, 2034 | Senior notes
Debt Instrument
Stated interest rate	5.65%
Debt outstanding	$ 250,000	$ 250,000
Effective interest rate	5.67%	5.67%
Fixed-rate 4.100% Senior Notes due on March 15, 2029 | Senior notes
Debt Instrument
Stated interest rate	4.10%
Debt outstanding	$ 800,000	$ 800,000
Effective interest rate	4.159%	4.159%
Fixed-rate 5.000% Senior Notes due on March 15, 2049 | Senior notes
Debt Instrument
Stated interest rate	5%
Debt outstanding	$ 400,000	$ 400,000
Effective interest rate	5.047%	5.047%
Fixed-rate 3.300% Senior Notes due on March 1, 2050 | Senior notes
Debt Instrument
Stated interest rate	3.30%
Debt outstanding	$ 750,000	$ 750,000
Effective interest rate	3.302%	3.302%
Fixed-rate 4.650% Senior Notes due on July 15, 2032 | Senior notes
Debt Instrument
Stated interest rate	4.65%	4.65%
Debt outstanding	$ 1,000,000	$ 1,000,000
Effective interest rate	4.657%	4.657%
Fixed-rate 4.950% Senior Notes due on July 15, 2052 | Senior notes
Debt Instrument
Stated interest rate	4.95%	4.95%
Debt outstanding	$ 1,200,000	$ 1,200,000
Effective interest rate	5.009%	5.009%
Fixed-rate 5.250% Senior Notes due on July 15, 2062 | Senior notes
Debt Instrument
Stated interest rate	5.25%	5.25%
Debt outstanding	$ 800,000	$ 800,000
Effective interest rate	5.259%	5.259%

DEBT - Senior Notes and Debt Re

DEBT - Senior Notes and Debt Redemption (Details) - USD ($)	3 Months Ended			9 Months Ended
	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	Feb. 29, 2020	Mar. 31, 2019	Nov. 30, 2014
Debt Instrument
Loss on extinguishment of debt	$ 0		$ 0	$ 13,286,000	$ 0
Senior notes
Debt Instrument
Redemption price				101%
Fair value disclosure	$ 5,790,000,000			$ 5,790,000,000			$ 6,390,000,000
Senior notes | 2022 Senior Notes
Debt Instrument
Debt face amount							3,000,000,000
Senior notes | Fixed-rate 4.650% Senior Notes due on July 15, 2032
Debt Instrument
Debt face amount							$ 1,000,000,000
Stated interest rate	4.65%			4.65%			4.65%
Senior notes | Fixed-rate 4.950% Senior Notes due on July 15, 2052
Debt Instrument
Debt face amount							$ 1,200,000,000
Stated interest rate	4.95%			4.95%			4.95%
Senior notes | Fixed-rate 5.250% Senior Notes due on July 15, 2062
Debt Instrument
Debt face amount							$ 800,000,000
Stated interest rate	5.25%			5.25%			5.25%
Senior notes | 2024 Senior Notes
Debt Instrument
Stated interest rate	4.65%			4.65%
Debt repurchase amount						$ 500,000,000
Loss on extinguishment of debt		$ 13,300,000
Senior notes | 2020 Senior Notes
Debt Instrument
Debt face amount								$ 750,000,000
Senior notes | 2019 Senior Notes
Debt Instrument
Debt face amount									$ 1,200,000,000
Senior notes | 2014 Senior Notes
Debt Instrument
Debt face amount										$ 2,500,000,000

DEBT - Revolving Credit Facilit

DEBT - Revolving Credit Facility (Details)	1 Months Ended	3 Months Ended	9 Months Ended
	Nov. 30, 2017	Mar. 31, 2023 USD ($) extension quarter	Mar. 31, 2023 USD ($) extension	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)
Debt Instrument
Proceeds from revolving credit facility			$ 300,000,000	$ 600,000,000
Line of credit | Revolving credit facility
Debt Instrument
Maximum borrowing capacity		$ 1,500,000,000	1,500,000,000
Increase of borrowing capacity		250,000,000	250,000,000
Proceeds from revolving credit facility			300,000,000
Repayments of lines of credit			575,000,000
Debt outstanding		$ 0	$ 0		$ 275,000,000
Debt number of extension | extension		2	2
Extension period (in year)			1 year
Commitment fee percentage (in bps)			0.09%
Maximum leverage ratio		3.50	3.50
Covenant compliance, number of consecutive quarters | quarter		4
Maximum leverage ratio under a material acquisition or series of material acquisitions		4	4
Line of credit | Revolving credit facility | Minimum
Debt Instrument
Commitment fee percentage (in bps)	0.045%
Line of credit | Revolving credit facility | Maximum
Debt Instrument
Commitment fee percentage (in bps)	0.125%
Line of credit | Revolving credit facility | SOFR
Debt Instrument
Basis spread on variable rate (in bps)	0.10%		1%
Line of credit | Revolving credit facility | SOFR | Minimum
Debt Instrument
Basis spread on variable rate (in bps)	0.75%
Line of credit | Revolving credit facility | SOFR | Maximum
Debt Instrument
Basis spread on variable rate (in bps)	1.25%
Line of credit | Revolving credit facility | Alternative base rate | Minimum
Debt Instrument
Basis spread on variable rate (in bps)	0%
Line of credit | Revolving credit facility | Alternative base rate | Maximum
Debt Instrument
Basis spread on variable rate (in bps)	0.25%

LEASES - Additional Information

LEASES - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Lessee, Lease, Description [Line Items]
Total lease expense	$ 10.1	$ 9.2	$ 29.2	$ 27.5
Operating leases, weighted average remaining lease term	6 years 6 months		6 years 6 months		4 years 9 months 18 days
Operating leases, weighted average discount rate	3.26%		3.26%		2.18%
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease terms			1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease terms			29 years

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating cash outflows from operating leases	$ 29,630	$ 28,680
Right of use assets obtained in exchange for new operating lease liabilities	$ 85,911	$ 20,698

LEASES - Maturities of Lease Li

LEASES - Maturities of Lease Liabilities (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Operating Leases, After Adoption of 842
2023 (remaining three months)	$ 10,503
2024	33,605
2025	32,942
2026	26,363
2027	21,511
2028 and thereafter	72,457
Total lease payments	197,381
Less imputed interest	(26,048)
Total	$ 171,333

EQUITY, LONG-TERM INCENTIVE C_3

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Equity Incentive Program and Assumed Equity Plans (Details) - shares	Mar. 31, 2023	Jun. 30, 2022
2004 Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares available for grant (in shares)	8,318,000	9,242,000
Assumed Equity Plans
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Assumed award outstanding (in shares)	0

EQUITY, LONG-TERM INCENTIVE C_4

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Equity Incentive Plans General Information (Details) shares in Thousands	9 Months Ended
	Mar. 31, 2023 shares
Restricted stock unit, Performance-based and Service-based | Senior Management
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted stock units granted (in shares)	(600)
2004 Plan
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in shares)	9,242
Restricted stock units granted (in shares)	(1,012)
Restricted stock units canceled (in shares)	88
Ending balance (in shares)	8,318
Impact on share reserve multiplier	2
2004 Plan | Restricted stock unit, Performance-based and Service-based
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Ending balance (in shares)	300

EQUITY, LONG-TERM INCENTIVE C_5

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Share-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Stock-based compensation expense
Stock-based compensation expense	$ 48,130	$ 37,087	$ 121,517	$ 90,069
Stock-based compensation capitalized as inventory	15,900		15,900		$ 8,600
Costs of revenues
Stock-based compensation expense
Stock-based compensation expense	8,596	6,543	20,189	14,475
R&D
Stock-based compensation expense
Stock-based compensation expense	13,289	8,482	30,437	18,077
SG&A
Stock-based compensation expense
Stock-based compensation expense	$ 26,245	$ 22,062	$ 70,891	$ 57,517

EQUITY, LONG-TERM INCENTIVE C_6

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Restricted Stock Unit Activities (Details) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2022 $ / shares	Mar. 31, 2023 USD ($) Installment $ / shares shares	Mar. 31, 2022 $ / shares	Jun. 30, 2022 shares
Restricted stock units
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Granted (in dollars per share) | $ / shares	$ 409.77	$ 388.03	$ 390.53	$ 358.38
Unrecognized stock-based compensation balance | $	$ 294.4		$ 294.4
Estimated weighted-average amortization period			1 year 4 months 24 days
Intrinsic value | $	$ 638.5		$ 638.5
Restricted stock unit, Service-based | Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based vesting period			2 years
Restricted stock unit, Service-based | Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based vesting period			4 years
Restricted Stock Unit, Market-based and Service-based
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Service and performance-based, number of equal vesting installments | Installment			3
Restricted Stock Unit, Market-based and Service-based | Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based vesting period			3 years
Restricted Stock Unit, Market-based and Service-based | Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based vesting period			4 years
2004 Plan
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Number of shares available for grant (in shares)	8,318		8,318		9,242
2004 Plan | Restricted stock units
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding restricted stock units, beginning (in shares)			1,593
Granted (in shares)			506
Vested and released (in shares)			(264)
Withheld for taxes (in shares)			(190)
Forfeited (in shares)			(45)
Outstanding restricted stock units, ending (in shares)	1,600		1,600
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding restricted stock units, beginning (in dollars per share) | $ / shares			$ 218.03
Granted (in dollars per share) | $ / shares			390.53
Vested and released (in dollars per share) | $ / shares			147.65
Withheld for taxes (in dollars per share) | $ / shares			147.65
Forfeited (in dollars per share) | $ / shares			179.82
Outstanding restricted stock units, ending (in dollars per share) | $ / shares	$ 293.58		$ 293.58
2004 Plan | Restricted stock unit, Performance-based and Service-based
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Number of shares available for grant (in shares)	300		300

EQUITY, LONG-TERM INCENTIVE C_7

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Weighted-Average Grant Date Fair Value (Details) - Restricted stock units - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted-average grant date fair value per unit (in dollars per share)	$ 409.77	$ 388.03	$ 390.53	$ 358.38
Grant date fair value of vested RSUs	$ 9,217	$ 10,150	$ 67,152	$ 57,453
Tax benefits realized by us in connection with vested and released RSUs	$ 4,517	$ 3,993	$ 17,368	$ 17,914

EQUITY, LONG-TERM INCENTIVE C_8

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Cash-Based Long-Term Incentive Compensation (Details) - Cash LTI Plan $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) Installment	Mar. 31, 2022 USD ($)
Cash Long-Term Incentive Plan
Cash-based long-term incentive plan, authorized amount			$ 0.2	$ 15.7
Cash long-term incentive plan, compensation expense	$ 19.5	$ 21.6	58.5	$ 65.6
Cash long-term incentive plan, unrecognized compensation balance	$ 110.1		$ 110.1
Minimum
Cash Long-Term Incentive Plan
Cash long-term incentive plan, equal vesting installments | Installment			3
Cash long-term incentive plan, percentage of equal vesting installments			33.33%
Cash long-term incentive plan, vesting period			3 years
Maximum
Cash Long-Term Incentive Plan
Cash long-term incentive plan, equal vesting installments | Installment			4
Cash long-term incentive plan, percentage of equal vesting installments			25%
Cash long-term incentive plan, vesting period			4 years

EQUITY, LONG-TERM INCENTIVE C_9

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Employee Stock Purchase Plan (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
ESPP, offering period			6 months
Employee Stock Purchase Plan Additional Information
ESPP maximum annual share replenishment (in shares)	2,000		2,000
Employee Stock Purchase Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
ESPP maximum employee subscription rate	15%		15%
ESPP, discount from market price, lesser of commencement of offering period or purchase date			85%
ESPP, Fair Value Assumptions and Methodology
Expected stock price volatility	43.80%	41.50%	42.70%	38.20%
Risk-free interest rate	3.90%	0.10%	2.50%	0.10%
Dividend yield	1.40%	1%	1.60%	1.20%
Expected life (in years)	6 months	6 months	6 months	6 months
Employee Stock Purchase Plan Additional Information
Total cash received from employees for the issuance of shares under the ESPP	$ 0	$ 0	$ 33,793	$ 36,912
Number of shares purchased by employees through the ESPP (in shares)	0	0	134	139
Tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP	$ 616	$ 488	$ 1,540	$ 1,686
Weighted-average fair value per share based on Black-Scholes model (in dollars per share)	$ 97.32	$ 107.45	$ 89.81	$ 94.91
Number of shares available for grant (in shares)	2,500		2,500

EQUITY, LONG-TERM INCENTIVE _10

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Quarterly Cash Dividends (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended		9 Months Ended
	Mar. 01, 2023	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Dividends Payable
Cash dividends paid per share (in dollars per share)	$ 1.30
Restricted stock unit, Performance-based and Service-based
Dividends Payable
Dividends payable		$ 11.7		$ 11.7		$ 11.2
Additional paid-in capital
Dividends Payable
Payment of dividends		$ 180.9	$ 159	$ 553	$ 480.9

EQUITY, LONG-TERM INCENTIVE _11

EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST - Non-Controlling Interest (Details)	Jun. 30, 2022
Orbograph
Noncontrolling Interest [Line Items]
Non-controlling interest, ownership	94%

STOCK REPURCHASE PROGRAM - Addi

STOCK REPURCHASE PROGRAM - Additional Information (Details) $ / shares in Units, shares in Millions		3 Months Ended
	Jun. 23, 2022 USD ($) financialInstitution	Dec. 31, 2022 USD ($) $ / shares	Jun. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)	Mar. 31, 2023 USD ($)
Equity [Abstract]
Increase of stock repurchase program authorized amount			$ 6,000,000,000	$ 2,000,000,000
ASR agreement, number of financial institutions | financialInstitution	2
ASR agreement, upfront payment	$ 3,000,000,000
ASR agreement, number of shares received (in shares) | shares			6.5
ASR agreement, percentage of prepayment amount at market price	70%
ASR agreement, adjustment	$ 900,000,000
ASR agreement, final settlement received		$ 2,400,000
ASR agreement, average share price (in dollars per share) | $ / shares		$ 333.88
Remaining shares authorized to be repurchased, amount					$ 2,290,000,000

STOCK REPURCHASE PROGRAM - Summ

STOCK REPURCHASE PROGRAM - Summary of Share Repurchase Transactions (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Equity, Class of Treasury Stock
Total cost of repurchases	$ 482,712	$ 370,982	$ 89,616	$ 564,666	$ 429,874	$ 399,677	$ 943,310	$ 1,394,217
Common Stock and Capital in Excess of Par Value, Shares
Equity, Class of Treasury Stock
Number of shares of common stock repurchased (in shares)	1,227	3,429	257	1,539	1,104	1,190	4,913	3,833

NET INCOME PER SHARE (Details)

NET INCOME PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net income attributable to KLA	$ 697,837	$ 978,795	$ 1,025,991	$ 730,572	$ 717,444	$ 1,068,417	$ 2,702,623	$ 2,516,433
Denominator:
Weighted-average shares - basic, excluding unvested RSU's (in shares)	137,865			150,145			140,349	151,250
Effect of dilutive RSUs and options (in shares)	780			1,041			724	1,096
Weighted-average shares - diluted (in shares)	138,645			151,186			141,073	152,346
Basic net income per share attributable to KLA (in dollars per share)	$ 5.06			$ 4.87			$ 19.26	$ 16.64
Diluted net income per share attributable to KLA (in dollars per share)	$ 5.03			$ 4.83			$ 19.16	$ 16.52
Anti-dilutive securities excluded from the computation of diluted net income per share (in shares)	12			10			226	9

INCOME TAXES - Details of Incom

INCOME TAXES - Details of Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income before income taxes	$ 800,683	$ 846,285	$ 3,013,684	$ 2,539,538
Provision for income taxes	$ 102,846	$ 115,625	$ 310,987	$ 22,876
Effective tax rate	12.80%	13.70%	10.30%	0.90%

INCOME TAXES - Additional Infor

INCOME TAXES - Additional Information (Details) - Foreign Tax Authority - ITA - Orbotech $ in Millions	1 Months Ended
	Aug. 31, 2022 USD ($)
Income Tax Examination
Income tax examination, settlement payment including interest	$ 25.7
Income tax examination, refund adjustment from settlement	5.7
Income tax examination, current year election payment amount	$ 16.2

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) Installment	Mar. 31, 2022 USD ($)
Receivables Sold Under Factoring Agreements and Proceeds from Sales of LC
Receivables sold under factoring agreements	$ 107,140	$ 63,094	$ 288,599	$ 210,130
Proceeds from sales of LC	0	$ 74,267	69,247	$ 115,433
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits
Purchase commitments	2,900,000		$ 2,900,000
Purchase commitment, period			12 months
Cash-based long-term incentive plan, committed amount	183,700		$ 183,700
Guarantee arrangements to fund customs guarantees for VAT and other operating requirements	77,500		77,500
Outstanding guarantee arrangements to fund customs authorities for VAT and other operating requirements	$ 43,700		$ 43,700
Minimum | Cash LTI Plan
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits
Cash long-term incentive plan, equal vesting installments | Installment			3
Cash long-term incentive plan, percentage of equal vesting installments			33.33%
Cash long-term incentive plan, vesting period			3 years
Maximum | Cash LTI Plan
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits
Cash long-term incentive plan, equal vesting installments | Installment			4
Cash long-term incentive plan, percentage of equal vesting installments			25%
Cash long-term incentive plan, vesting period			4 years

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023 USD ($) derivativeInstrument	Mar. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) derivativeInstrument	Mar. 31, 2022 USD ($)
Derivative
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	$ 2,824	$ 992	$ 25,960	$ 3,122
Treasury lock
Derivative
Number of derivative instruments held | derivativeInstrument	4		4
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	$ 900	$ 300	$ 2,800	$ 800
Derivatives designated as hedging instruments | Cash Flow Hedging | Treasury lock
Derivative
Unamortized portion of the fair value of derivative contracts	$ 52,000		$ 52,000
Maximum | Derivatives designated as hedging instruments | Cash Flow Hedging
Derivative
Term of contract			18 months

DERIVATIVE INSTRUMENTS AND HE_4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) on Derivatives in Cash Flow Hedging Relationships Recognized in OCI (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Derivative
Amounts included in the assessment of effectiveness	$ 6,660,000	$ 17,777,000	$ 16,667,000	$ 25,370,000
Rate lock agreements | Cash Flow Hedging
Derivative
Amounts included in the assessment of effectiveness	0	10,069,000	0	10,069,000
Foreign exchange contracts | Cash Flow Hedging
Derivative
Amounts included in the assessment of effectiveness	6,008,000	7,733,000	16,720,000	15,335,000
Amounts excluded from the assessment of effectiveness	652,000	(25,000)	(53,000)	(34,000)
Foreign exchange contracts | Net investment hedging
Derivative
Amounts excluded from the assessment of effectiveness	0	0	0	0
Gains (losses) on derivatives in net investment hedging recognized in OCI	$ 154,000	$ 1,850,000	$ 1,986,000	$ 1,386,000

DERIVATIVE INSTRUMENTS AND HE_5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Locations and Amounts of Designated and Non-Designated Derivative's Gains and Losses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Derivative Instruments
Revenues	$ 2,432,608	$ 2,288,676	$ 8,140,919	$ 6,725,144
Costs of revenues and operating expenses	1,572,015	1,393,769	4,970,444	4,045,479
Interest expense	74,774	39,978	223,449	116,142
Other expense (income), net	(14,864)	8,644	(79,944)	23,985
Amount of gains (losses) reclassified from AOCI to earnings	2,824	992	25,960	3,122
Rate lock agreements | Revenues
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	0	0	0	0
Rate lock agreements | Costs of Revenues and Operating Expenses
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	0	0	0	0
Rate lock agreements | Interest Expense
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	936	(279)	2,810	(837)
Rate lock agreements | Other Expense (Income), Net
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	0	0	0	0
Foreign exchange contracts | Revenues
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	1,748	1,711	33,024	5,197
Amount excluded from the assessment of effectiveness recognized in earnings	(327)	(111)	(1,070)	(329)
Amount of gains (losses) recognized in earnings	0	0	0	0
Foreign exchange contracts | Costs of Revenues and Operating Expenses
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	467	(329)	(8,804)	(909)
Amount excluded from the assessment of effectiveness recognized in earnings	0	0	0	0
Amount of gains (losses) recognized in earnings	0	0	0	0
Foreign exchange contracts | Interest Expense
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	0	0	0	0
Amount excluded from the assessment of effectiveness recognized in earnings	0	0	0	0
Amount of gains (losses) recognized in earnings	0	0	0	0
Foreign exchange contracts | Other Expense (Income), Net
Derivative Instruments
Amount of gains (losses) reclassified from AOCI to earnings	0	0	0	0
Amount excluded from the assessment of effectiveness recognized in earnings	765	568	1,675	1,883
Amount of gains (losses) recognized in earnings	$ (9,066)	$ (2,802)	$ (2,773)	$ 4,261

DERIVATIVE INSTRUMENTS AND HE_6

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Notional Amount (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Derivative
Remaining maturity	14 months	14 months
Derivatives designated as hedging instruments | Purchase | Other foreign currency hedge contracts
Derivative
Derivative, notional amount	$ 572,609	$ 565,586
Derivatives designated as hedging instruments | Purchase | Cash Flow Hedging | Foreign exchange contracts
Derivative
Derivative, notional amount	192,875	124,641
Derivatives designated as hedging instruments | Sell | Other foreign currency hedge contracts
Derivative
Derivative, notional amount	296,379	389,368
Derivatives designated as hedging instruments | Sell | Cash Flow Hedging | Foreign exchange contracts
Derivative
Derivative, notional amount	146,207	176,259
Derivatives designated as hedging instruments | Sell | Net Investment Hedging | Foreign exchange contracts
Derivative
Derivative, notional amount	$ 87,157	$ 66,436

DERIVATIVE INSTRUMENTS AND HE_7

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Asset derivatives fair value	$ 20,291	$ 40,311
Liability derivatives fair value	13,196	34,315
Other current assets
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Asset derivatives fair value	20,291	40,311
Other current liabilities
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Liability derivatives fair value	(13,196)	34,315
Derivatives designated as hedging instruments | Other current assets
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Asset derivatives fair value	15,192	20,595
Derivatives designated as hedging instruments | Other current liabilities
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Liability derivatives fair value	(1,504)	8,406
Derivatives not designated as hedging instruments | Other current assets
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Asset derivatives fair value	5,099	19,716
Derivatives not designated as hedging instruments | Other current liabilities
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Liability derivatives fair value	(11,692)	25,909
Foreign exchange contracts | Derivatives designated as hedging instruments | Other current assets
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Asset derivatives fair value	15,192	20,595
Foreign exchange contracts | Derivatives designated as hedging instruments | Other current liabilities
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Liability derivatives fair value	(1,504)	8,406
Foreign exchange contracts | Derivatives not designated as hedging instruments | Other current assets
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Asset derivatives fair value	5,099	19,716
Foreign exchange contracts | Derivatives not designated as hedging instruments | Other current liabilities
Derivative Assets and Liabilities, at Fair Value, Net, by Balance Sheet Classification
Liability derivatives fair value	$ (11,692)	$ 25,909

DERIVATIVE INSTRUMENTS AND HE_8

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Changes of OCI, Before Taxes, Related to Derivatives (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance			$ 1,401,351
Ending balance	$ 2,682,781		2,682,781
AOCI, derivative
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance	65,721	$ (20,831)	77,018	$ (25,830)
Amount reclassified to earnings as net (gains) losses	(2,824)	(992)	(25,960)	(3,122)
Net change in unrealized gains (losses)	6,814	19,627	18,653	26,756
Ending balance	$ 69,711	$ (2,196)	$ 69,711	$ (2,196)

DERIVATIVE INSTRUMENTS AND HE_9

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Offsetting of Derivative Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Derivatives - assets
Derivative - assets, Gross Amounts of Derivatives	$ 20,291	$ 40,311
Derivatives - assets, Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets	0	0
Derivatives - assets, Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets	20,291	40,311
Derivatives - assets, Financial Instruments	(10,113)	(12,291)
Derivatives - assets, Cash Collateral Received	0	0
Derivatives - assets, Net Amount	10,178	28,020
Derivatives - liabilities
Derivatives - liabilities, Gross Amounts of Derivatives	(13,196)	(34,315)
Derivatives - liabilities, Gross Amounts of Derivatives Offset in the Condensed Consolidated Balance Sheets	0	0
Derivatives - liabilities, Net Amount of Derivatives Presented in the Condensed Consolidated Balance Sheets	(13,196)	(34,315)
Derivatives - liabilities, Financial Instruments	10,113	12,291
Derivatives - liabilities, Cash Collateral Received	0	0
Derivatives - liabilities, Net Amount	$ (3,083)	$ (22,024)

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Related Party Transactions [Abstract]
Total revenues	$ 6,251	$ 4,485	$ 18,050	$ 5,108
Total purchases	462	$ 562	3,742	$ 834
Accounts receivables	$ 8,400		$ 8,400		$ 1,100

SEGMENT REPORTING AND GEOGRAP_3

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION - Additional Information (Details) - segment	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting and Geographic Information
Number of reportable segments			3
Number of operating segments			5
Customer Concentration Risk | Revenue from Contract with Customer Benchmark | Largest Customer
Segment Reporting and Geographic Information
Concentration risk, percentage	18%	17%	20%	22%
Customer Concentration Risk | Revenue from Contract with Customer Benchmark | Second Largest Customer
Segment Reporting and Geographic Information
Concentration risk, percentage	16%	16%	15%	12%
Semiconductor Process Control
Segment Reporting and Geographic Information
Number of operating segments			2
Specialty Semiconductor Process
Segment Reporting and Geographic Information
Number of operating segments			1
PCB, Display and Component Inspection
Segment Reporting and Geographic Information
Number of operating segments			2

SEGMENT REPORTING AND GEOGRAP_4

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION - Summary of Results for Reportable Segments (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 USD ($)
Segment Reporting and Geographic Information
Number of reportable segments | segment			3
Revenues	$ 2,432,608	$ 2,288,676	$ 8,140,919	$ 6,725,144
Operating segments
Segment Reporting and Geographic Information
Revenues	2,431,918	2,289,081	8,143,728	6,725,918
Segment gross profit	1,476,575	1,439,269	5,022,212	4,235,928
Operating segments | Semiconductor Process Control:
Segment Reporting and Geographic Information
Revenues	2,171,557	1,979,295	7,226,711	5,810,580
Segment gross profit	1,367,886	1,284,450	4,622,905	3,789,316
Operating segments | Specialty Semiconductor Process
Segment Reporting and Geographic Information
Revenues	128,438	117,253	414,390	332,020
Segment gross profit	65,328	61,521	216,408	176,516
Operating segments | PCB, Display and Component Inspection
Segment Reporting and Geographic Information
Revenues	131,923	192,533	502,627	583,318
Segment gross profit	$ 43,361	$ 93,298	$ 182,899	$ 270,096

SEGMENT REPORTING AND GEOGRAP_5

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION - Reconciliation of Total Reportable Segments Revenue to Total Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 2,432,608	$ 2,288,676	$ 8,140,919	$ 6,725,144
Operating segments
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	2,431,918	2,289,081	8,143,728	6,725,918
Corporate allocations and effects of changes in foreign currency exchange rates
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 690	$ (405)	$ (2,809)	$ (774)

SEGMENT REPORTING AND GEOGRAP_6

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION - Reconciliation of Total Segment Gross Margin to Total Income Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Acquisition-related charges, corporate allocations, and effects of changes in foreign currency exchange rates	$ 49,313	$ 42,684	$ 136,651	$ 124,661
R&D	328,276	285,189	979,617	808,373
SG&A	238,393	216,489	735,469	623,229
Interest expense	74,774	39,978	223,449	116,142
Loss on extinguishment of debt	0	0	13,286	0
Other expense (income), net	(14,864)	8,644	(79,944)	23,985
Income before income taxes	800,683	846,285	3,013,684	2,539,538
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total segment gross profit	$ 1,476,575	$ 1,439,269	$ 5,022,212	$ 4,235,928

SEGMENT REPORTING AND GEOGRAP_7

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION - Schedule of Revenue from External Customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting and Geographic Information
Revenues	$ 2,432,608	$ 2,288,676	$ 8,140,919	$ 6,725,144
Taiwan
Segment Reporting and Geographic Information
Revenues	478,855	515,097	1,996,188	1,918,623
China
Segment Reporting and Geographic Information
Revenues	635,018	709,502	2,156,380	1,939,195
Korea
Segment Reporting and Geographic Information
Revenues	468,226	474,019	1,466,624	1,036,297
North America
Segment Reporting and Geographic Information
Revenues	341,376	219,267	941,771	668,601
Japan
Segment Reporting and Geographic Information
Revenues	215,531	132,829	542,823	426,881
Europe and Israel
Segment Reporting and Geographic Information
Revenues	209,136	164,246	702,986	504,278
Rest of Asia
Segment Reporting and Geographic Information
Revenues	$ 84,466	$ 73,716	$ 334,147	$ 231,269
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark
Segment Reporting and Geographic Information
Concentration risk, percentage	100%	100%	100%	100%
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | Taiwan
Segment Reporting and Geographic Information
Concentration risk, percentage	20%	22%	24%	29%
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | China
Segment Reporting and Geographic Information
Concentration risk, percentage	26%	31%	26%	29%
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | Korea
Segment Reporting and Geographic Information
Concentration risk, percentage	19%	21%	18%	16%
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | North America
Segment Reporting and Geographic Information
Concentration risk, percentage	14%	10%	12%	10%
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | Japan
Segment Reporting and Geographic Information
Concentration risk, percentage	9%	6%	7%	6%
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | Europe and Israel
Segment Reporting and Geographic Information
Concentration risk, percentage	9%	7%	9%	7%
Geographic Concentration Risk | Revenue from Contract with Customer Benchmark | Rest of Asia
Segment Reporting and Geographic Information
Concentration risk, percentage	3%	3%	4%	3%

SEGMENT REPORTING AND GEOGRAP_8

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION - Revenue from External Customers by Products and Services (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Revenue from External Customer
Revenues	$ 2,432,608	$ 2,288,676	$ 8,140,919	$ 6,725,144
Wafer Inspection
Revenue from External Customer
Revenues	1,027,191	919,072	3,386,273	2,910,616
Patterning
Revenue from External Customer
Revenues	611,631	610,821	2,206,263	1,559,197
Specialty Semiconductor Process
Revenue from External Customer
Revenues	114,896	105,832	374,882	303,884
PCB, Display and Component Inspection
Revenue from External Customer
Revenues	69,495	123,384	312,582	383,021
Services
Revenue from External Customer
Revenues	529,124	488,017	1,578,418	1,398,828
Other
Revenue from External Customer
Revenues	$ 80,271	$ 41,550	$ 282,501	$ 169,598
Product Concentration Risk | Revenue from Contract with Customer Benchmark
Revenue from External Customer
Concentration risk, percentage	100%	100%	100%	100%
Product Concentration Risk | Revenue from Contract with Customer Benchmark | Wafer Inspection
Revenue from External Customer
Concentration risk, percentage	42%	40%	42%	43%
Product Concentration Risk | Revenue from Contract with Customer Benchmark | Patterning
Revenue from External Customer
Concentration risk, percentage	25%	27%	27%	23%
Product Concentration Risk | Revenue from Contract with Customer Benchmark | Specialty Semiconductor Process
Revenue from External Customer
Concentration risk, percentage	5%	5%	5%	5%
Product Concentration Risk | Revenue from Contract with Customer Benchmark | PCB, Display and Component Inspection
Revenue from External Customer
Concentration risk, percentage	3%	5%	4%	6%
Product Concentration Risk | Revenue from Contract with Customer Benchmark | Services
Revenue from External Customer
Concentration risk, percentage	22%	21%	19%	21%
Product Concentration Risk | Revenue from Contract with Customer Benchmark | Other
Revenue from External Customer
Concentration risk, percentage	3%	2%	3%	2%

SEGMENT REPORTING AND GEOGRAP_9

SEGMENT REPORTING AND GEOGRAPHIC INFORMATION - Land, Property and Equipment, Net by Geographic Region (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Jun. 30, 2022
Revenues from External Customers and Long-Lived Assets
Land, property and equipment, net	$ 984,271	$ 849,929
United States
Revenues from External Customers and Long-Lived Assets
Land, property and equipment, net	644,799	547,454
Singapore
Revenues from External Customers and Long-Lived Assets
Land, property and equipment, net	152,275	146,057
Israel
Revenues from External Customers and Long-Lived Assets
Land, property and equipment, net	88,277	72,791
Europe
Revenues from External Customers and Long-Lived Assets
Land, property and equipment, net	60,827	55,370
Rest of Asia
Revenues from External Customers and Long-Lived Assets
Land, property and equipment, net	$ 38,093	$ 28,257

RESTRUCTURING CHARGES (Details)

RESTRUCTURING CHARGES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring charges	$ 19.1	$ 0	$ 35.9	$ 0.9
Restructuring reserve	$ 20.2		$ 20.2		$ 2.1